# COMMISSION DIRECTIVE 2009/2/EC
of 15 January 2009
amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances
(Text with EEA relevance)
## Preamble
THE COMMISSION OF THE EUROPEAN COMMUNITIES,
Having regard to the Treaty establishing the European Community,
Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances [^1] , and in particular Article 28 thereof,
Whereas:
**(1)** Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.
**(2)** Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.
**(3)** Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.
**(4)** Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.
**(5)** Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.
**(6)** The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.
**(7)** As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.
**(8)** The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.
**(9)** The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,
HAS ADOPTED THIS DIRECTIVE:
## **Article 1**
Directive 67/548/EEC is amended as follows. Annex I is amended as follows:
(a) the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;
(b) the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;
(c) the entries set out in Annex 1C to this Directive are deleted.
## **Article 2**
Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.
When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.
Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
## **Article 3**
This Directive shall enter into force on the twentieth day following that of its publication in the *Official Journal of the European Union* .
## **Article 4**
This Directive is addressed to the Member States.
## Final provisions
Done at Brussels, 15 January 2009. *For the Commission* Stavros DIMAS *Member of the Commission*
[^1] [OJ 196, 16.8.1967, p. 1](http://publications.europa.eu/resource/oj/JOP_1967_196_R_TOC) .
| Index No | Chemical name | Notes related to substances | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes related to preparations |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 001-002-00-4 | aluminium lithium hydride | | 240-877-9 | 16853-85-3 | F; R15
C; R35 | F; C
R: 15-35
S: (1/2-)7/8-26-36/37/39-43-45 | | |
| 005-006-00-7 | dibutyltin hydrogen borate | E | 401-040-5 | 75113-37-0 | Muta. Cat. 3; R68
Repr. Cat. 2; R60-61
T; R48/25
Xn; R21/22
Xi; R41
R43
N; R50-53 | T; N
R: 60-61-21/22-41-43-48/25-68-50/53
S: 53-45-60-61 | | |
| 006-007-00-5 | salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this Annex | A | — | — | T+; R26/27/28
R32
N; R50-53 | T+; N
R: 26/27/28-32-50/53
S: (1/2-)7-28-29-45-60-61 | | |
| 006-015-00-9 | diuron (ISO);
3-(3,4-dichlorophenyl)-1,1-dimethylurea | | 206-354-4 | 330-54-1 | Carc. Cat. 3; R40
Xn; R22-48/22
N; R50-53 | Xn; N
R: 22-40-48/22-50/53
S: (2-)13-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-40-48/22-50/53
10 % ≤ C < 25 %: Xn, N; R40-48/22-50/53
2,5 % ≤ C < 10 %: Xn, N; R40-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 006-076-00-1 | mancozeb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt | | — | 8018-01-7 | Repr. Cat. 3; R63
R43
N; R50 | Xn; N
R: 43-63-50
S: (2-)36/37-46-61 | C ≥ 5 %: Xn, N; R43-63-50
2,5 ≤ C < 5 %: Xi, N; R43-50
1 % ≤ C < 2,5 %: Xi; R43 | |
| 006-077-00-7 | maneb (ISO);
manganese ethylenebis(dithiocarbamate) (polymeric) | | 235-654-8 | 12427-38-2 | Repr. Cat. 3; R63
Xn; R20
Xi; R36
R43
N; R50-53 | Xn; N
R: 20-36-43-63-50/53
S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-36-43-63-50/53
20 % ≤ C < 25 %: Xn, N; R36-43-63-50/53
5 % ≤ C < 20 %: Xn, N; R43-63-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 006-084-00-5 | carbosulfan (ISO);
2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate | | 259-565-9 | 55285-14-8 | T+; R26
T; R25
R43
N; R50-53 | T+; N
R: 25-26-43-50/53
S: (1/2-)28-36/37-38-45-63-60-61 | | |
| 006-088-00-7 | benfuracarb (ISO);
ethyl *N* -[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]- *N* -isopropyl-β-alaninate | | — | 82560-54-1 | Repr. Cat. 3; R62
T; R23
Xn; R22
N; R50-53 | T; N
R: 22-23-62-50/53
S: (1/2-)36/37-45-60-61 | | |
| 007-002-00-0 | nitrogen dioxide; [1]
dinitrogen tetraoxide [2] | | 233-272-6 [1]
234-126-4 [2] | 10102-44-0 [1]
10544-72-6 [2] | O; R8
T+; R26
C; R34 | O; T+
R: 8-26-34
S: (1/2-)9-26-28-36/37/39-45 | C ≥ 10 %: T+; R26-34
5 % ≤ C < 10 %: T; R23-34
1 % ≤ C < 5 %: T; R23-36/37/38
0,5 % ≤ C < 1 %: Xn; R20-36/37/38
0,1 % ≤ C < 0,5 %: Xn; R20 | 5 |
| 015-041-00-X | malathion (ISO);
1,2-bis(ethoxycarbonyl)ethyl *O,O* -dimethyl phosphorodithioate;
[containing ≤ 0,03 % isomalathion] | | 204-497-7 | 121-75-5 | Xn; R22
R43
N; R50-53 | Xn; N
R: 22-43-50/53
S: (2-)24-37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
1 % ≤ C < 25 %: Xi, N; R43-50/53
0,025 % ≤ C < 1 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 015-100-00-X | phoxim (ISO);
α-(diethoxyphosphinothioylimino) phenylacetonitrile | | 238-887-3 | 14816-18-3 | Repr. Cat. 3; R62
Xn; R22
R43
N; R50-53 | Xn; N
R: 22-43-62-50/53
S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-62-50/53
5 % ≤ C < 25 %: Xn, N; R43-62-50/53
1 % ≤ C < 5 %: Xi, N; R43-50/53
0,025 % ≤ C < 1 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 015-102-00-0 | tris(2-chloroethyl)phosphate | E | 204-118-5 | 115-96-8 | Carc. Cat. 3; R40
Repr. Cat. 2; R60
Xn; R22
N; R51-53 | T; N
R: 60-22-40-51/53
S: 53-45-61 | | |
| 015-155-00-X | glufosinate ammonium (ISO);
ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrate | E | 278-636-5 | 77182-82-2 | Repr. Cat. 2; R60
Repr. Cat. 3; R63
Xn; R20/21/22-48/20/22 | T
R: 60-20/21/22-48/20/22-63
S: 53-45 | | |
| 016-009-00-8 | disodium sulfide;
sodium sulfide | | 215-211-5 | 1313-82-2 | T; R24
Xn; R22
C; R34
R31
N; R50 | T; C; N
R: 22-24-31-34-50
S: (1/2-)26-36/37/39-45-61 | | |
| 017-009-00-0 | ammonium perchlorate;
[containing ≥ 80 % of 0-30 μm particles] | T | 232-235-1 | 7790-98-9 | E; R3
O; R9 | E
R: 3-9
S: (2-)14-16-36/37 | | |
| 024-004-00-7 | sodium dichromate | E | 234-190-3 | 10588-01-9 | O; R8
Carc. Cat. 2; R45
Muta. Cat. 2; R46
Repr. Cat. 2; R60-61
T+; R26
T; R25-48/23
Xn; R21
C; R34
R42/43
N; R50-53 | O; T+; N
R: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53
S: 53-45-60-61 | C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/53
10 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/53
7 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/53
5 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/53
3 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/53
2,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/53
1 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/53
0,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/53
0,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/53
0,2 % ≤ C < 0,25 %: T; R45-46-20-42/43
0,1 % ≤ C < 0,2 %: T; R45-46-20 | 3 |
| 027-002-00-4 | cobalt oxide | | 215-154-6 | 1307-96-6 | Xn; R22
R43
N; R50-53 | Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
2,5 % ≤ C < 25 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 027-003-00-X | cobalt sulfide | | 215-273-3 | 1317-42-6 | R43
N; R50-53 | Xi; N
R: 43-50/53
S: (2-)24-37-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 028-003-00-2 | nickel monoxide; [1]
nickel oxide; [2]
bunsenite [3] | E | 215-215-7 [1]
234-323-5 [2]
- [3] | 1313-99-1 [1]
11099-02-8 [2]
34492-97-2 [3] | Carc. Cat. 1; R49
T; R48/23
R43
R53 | T
R: 49-43-48/23-53
S: 53-45-61 | | |
| 028-004-00-8 | nickel dioxide | E | 234-823-3 | 12035-36-8 | Carc. Cat. 1; R49
T; R48/23
R43
R53 | T
R: 49-43-48/23-53
S: 53-45-61 | | |
| 028-005-00-3 | dinickel trioxide | E | 215-217-8 | 1314-06-3 | Carc. Cat. 1; R49
T; R48/23
R43
R53 | T
R: 49-43-48/23-53
S: 53-45-61 | | |
| 028-006-00-9 | nickel (II) sulfide; [1]
nickel sulfide; [2]
millerite [3] | E | 240-841-2 [1]
234-349-7 [2]
- [3] | 16812-54-7 [1]
11113-75-0 [2]
1314-04-1 [3] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61 | | |
| 028-007-00-4 | trinickel disulfide;
nickel subsulfide; [1]
heazlewoodite [2] | E | 234-829-6 [1]
- [2] | 12035-72-2 [1]
12035-71-1 [2] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-68-50/53
S: 53-45-60-61 | | |
| 028-008-00-X | nickel dihydroxide; [1]
nickel hydroxide [2] | E | 235-008-5 [1]
234-348-1 [2] | 12054-48-7 [1]
11113-74-9 [2] | Carc. Cat. 1; R49
Repr. Cat. 2; R61
Muta. Cat. 3; R68
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53 | T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61 | | |
| 029-013-00-X | trisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II) | | 407-580-8 | 130201-51-3 | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 033-005-00-1 | arsenic acid and its salts with the exception of those specified elsewhere in this Annex | AE | — | — | Carc. Cat. 1; R45
T; R23/25
N; R50-53 | T; N
R: 45-23/25-50/53
S: 53-45-60-61 | | |
| 034-002-00-8 | selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this Annex | A | — | — | T; R23/25
R33
N; R50-53 | T; N
R: 23/25-33-50/53
S: (1/2-)20/21-28-45-60-61 | | |
| 047-001-00-2 | silver nitrate | | 231-853-9 | 7761-88-8 | O; R8
C; R34
N; R50-53 | O; C; N
R: 8-34-50/53
S: (1/2-)26-36/37/39-45-60-61 | | |
| 050-002-00-0 | cyhexatin (ISO);
hydroxytricyclohexylstannane;
tri(cyclohexyl)tin hydroxide | | 236-049-1 | 13121-70-5 | Xn; R20/21/22
N; R50-53 | Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 | C ≥ 25 %: Xn, N; R20/21/22-50/53
0,025 % ≤ C < 25 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 050-003-00-6 | fentin acetate (ISO);
triphenyltin acetate | | 212-984-0 | 900-95-8 | Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53 | T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
0,25 % ≤ C < 1 %: Xn, N; R20-51/53
0,1 % ≤ C < 0,25 %: Xn; R20-52/53
0,025 % ≤ C < 0,1 %: R52/53 | |
| 050-004-00-1 | fentin hydroxide (ISO);
triphenyltin hydroxide | | 200-990-6 | 76-87-9 | Carc. Cat. 3; R40
Repr. Cat. 3; R63
T+; R26
T; R24/25-48/23
Xi; R37/38-41
N; R50-53 | T+; N
R: 24/25-26-37/38-40-41-48/23-63-50/53
S: (1/2-)26-28-36/37/39-45-60-61 | C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/53
20 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/53
10 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/53
7 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/53
5 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/53
3 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/53
2,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/53
1 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/53
0,25 % ≤ C < 1 %: Xn, N; R20-51/53
0,1 % ≤ C < 0,25 %: Xn; R20-52/53
0,025 % ≤ C < 0,1 %: R52/53 | |
| 050-008-00-3 | tributyltin compounds, with the exception of those specified elsewhere in this Annex | A | — | — | T; R25-48/23/25
Xn; R21
Xi; R36/38
N; R50-53 | T; N
R: 21-25-36/38-48/23/25-50/53
S: (1/2-)36/37/39-45-60-61 | C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/53
1 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/53
0,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/53
0,025 % C < 0,25 %: R52/53 | 1 |
| 050-011-00-X | triphenyltin compounds, with the exception of those specified elsewhere in this Annex | A | — | — | T; R23/24/25
N; R50-53 | T; N
R: 23/24/25-50/53
S: (1/2-)26-27-28-45-60-61 | C ≥ 1 %: T, N; R23/24/25-50/53
0,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53 | 1 |
| 050-018-00-8 | tin(II) methanesulphonate | | 401-640-7 | 53408-94-9 | C; R34
Xn; R22
R43
N; R51-53 | C; N
R: 22-34-43-51/53
S: (1/2-)22-26-36/37/39-45-61 | | |
| 053-003-00-4 | iodoxybenzene | | — | 696-33-3 | E; R2 | E
R: 2
S: (2-)35 | | |
| 053-004-00-X | calcium iodoxybenzoate | C | — | — | E; R2 | E
R: 2
S: (2-)35 | | |
| 080-001-00-0 | mercury | E | 231-106-7 | 7439-97-6 | Repr. Cat. 2; R61
T+; R26
T; R48/23
N; R50-53 | T+; N
R: 61-26-48/23-50/53
S: 53-45-60-61 | | |
| 080-010-00-X | mercury dichloride;
mercuric chloride | | 231-299-8 | 7487-94-7 | Muta. Cat. 3; R68
Repr. Cat. 3; R62
T+; R28
T; R48/24/25
C; R34
N; R50-53 | T+; N
R: 28-34-48/24/25-62-68-50/53
S: (1/2-)26-36/37/39-45-60-61 | | |
| 092-002-00-3 | uranium compounds with the exception of those specified elsewhere in this Annex | A | — | — | T+; R26/28
R33
N; R51-53 | T+; N
R: 26/28-33-51/53
S: (1/2-)20/21-45-61 | | |
| 601-065-00-3 | A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);
(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane) | | 416-930-9 | — | Xi; R38
N; R51-53 | Xi; N
R: 38-51/53
S: (2-)36/37-61 | | |
| 602-007-00-X | bromoform;
tribromomethane | | 200-854-6 | 75-25-2 | T; R23
Xn; R22
Xi; R36/38
N; R51-53 | T; N
R: 22-23-36/38-51/53
S: (1/2-)28-45-63-61 | | |
| 602-030-00-5 | 1,3-dichloropropene; [1]
( *Z* )-1,3-dichloropropene [2] | C D | 208-826-5 [1]
233-195-8 [2] | 542-75-6 [1]
10061-01-5 [2] | R10
T; R24/25
Xn; R20-65
Xi; R36/37/38
R43
N; R50-53 | T; N
R: 10-20-24/25-36/37/38-43-65-50/53
S: (1/2-)36/37-45-60-61 | | |
| 602-054-00-6 | 3-iodpropene;
allyl iodide | | 209-130-4 | 556-56-9 | F; R11
C; R34 | F; C
R: 11-34
S: (1/2-)7-16-26-45 | | |
| 603-005-00-1 | 2-methylpropan-2-ol;
*tert* -butyl alcohol | | 200-889-7 | 75-65-0 | F; R11
Xn; R20
Xi; R36/37 | F; Xn
R: 11-20-36/37
S: (2-)9-16-46 | | |
| 603-018-00-2 | furfuryl alcohol | | 202-626-1 | 98-00-0 | Carc. Cat. 3; R40
T; R23
Xn; R21/22-48/20
Xi; R36/37 | T
R: 21/22-23-36/37-40-48/20
S: (1/2-)36/37-45-63 | | |
| 603-023-00-X | ethylene oxide;
oxirane | E | 200-849-9 | 75-21-8 | F+; R12
R6
Carc. Cat. 2; R45
Muta. Cat. 2; R46
T; R23
Xi; R36/37/38 | F+; T
R: 45-46-6-12-23-36/37/38
S: 53-45 | | |
| 603-029-00-2 | bis(2-chloroethyl) ether | | 203-870-1 | 111-44-4 | Carc. Cat. 3; R40
T+; R26/27/28 | T+
R: 26/27/28-40
S: (1/2-)7/9-27-28-36/37-45 | C ≥ 7 %: T+; R26/27/28-40
1 % ≤ C < 7 %: T; R23/24/25-40
0,1 % ≤ C < 1 %: Xn; R20/21/22 | |
| 603-037-00-6 | cellulose nitrate;
nitrocellulose | T | — | — | E; R3 | E
R: 3
S: (2-)35 | | |
| 603-046-00-5 | bis(chloromethyl) ether;
oxybis(chloromethane) | E | 208-832-8 | 542-88-1 | F; R11
Carc. Cat. 1; R45
T+; R26
T; R24
Xn; R22 | F; T+
R: 45-11-22-24-26
S: 53-45 | C ≥ 25 %: T+; R45-22-24-26
7 % ≤ C < 25 %: T+; R45-21-26
3 % ≤ C < 7 %: T; R45-21-23
1 % ≤ C < 3 %: T; R45-23
0,1 % ≤ C < 1 %: T; R45-20
0,001 % ≤ C < 0,1 %: T; R45 | |
| 603-064-00-3 | 1-methoxy-2-propanol;
monopropylene glycol methyl ether | | 203-539-1 | 107-98-2 | R10
R67 | R: 10-67
S: (2-) | | |
| 603-066-00-4 | 1,2-epoxy-4-epoxyethylcyclohexane;
4-vinylcyclohexene diepoxide | | 203-437-7 | 106-87-6 | Carc. Cat. 3; R40
T; R23/24/25 | T
R: 23/24/25-40
S: (1/2-)36/37-45-63 | C ≥ 1 %: T; R23/24/25-40
0,1 % ≤ C < 1 %: Xn; R20/21/22 | |
| 605-004-00-1 | 2,4,6-trimethyl-1,3,5-trioxane;
paraldehyde | | 204-639-8 | 123-63-7 | R10 | R: 10
S: (2-)29 | | |
| 605-005-00-7 | 2,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;
metaldehyde | | 203-600-2 | 108-62-3 | F; R11
Xn; R22 | F; Xn
R: 11-22
S: (2-)13-16-25-46 | | |
| 606-021-00-7 | *N* -methyl-2-pyrrolidone;
1-methyl-2-pyrrolidone | | 212-828-1 | 872-50-4 | Repr. Cat. 2; R61
Xi; R36/37/38 | T
R: 61-36/37/38
S: 53-45 | C ≥ 10 %: T; R61-36/37/38
5 % ≤ C < 10 %: T; R61 | |
| 607-007-00-3 | salts of oxalic acid with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R21/22 | Xn
R: 21/22
S: (2-)24/25 | C ≥ 5 %: Xn; R21/22 | |
| 607-012-00-0 | benzoyl chloride | | 202-710-8 | 98-88-4 | Xn; R20/21/22
C; R34
R43 | C
R: 20/21/22-34-43
S: (1/2-)26-36/37/39-45 | | |
| 607-037-00-7 | 2-ethoxyethyl acetate;
ethylglycol acetate | E | 203-839-2 | 111-15-9 | R10
Repr. Cat. 2; R60-61
Xn; R20/21/22 | T
R: 60-61-10-20/21/22
S: 53-45 | | |
| 607-051-00-3 | MCPA (ISO);
4-chloro- *o* -tolyloxyacetic acid | | 202-360-6 | 94-74-6 | Xn; R22
Xi; R38-41
N; R50-53 | Xn; N
R: 22-38-41-50/53
S: (2-)26-37-39-60-61 | | |
| 607-052-00-9 | salts and esters of MCPA | A | — | — | Xn; R20/21/22
N; R50-53 | Xn; N
R: 20/21/22-50/53
S: (2-)13-60-61 | | |
| 607-085-00-9 | benzyl benzoate | | 204-402-9 | 120-51-4 | Xn; R22
N; R51-53 | Xn; N
R: 22-51/53
S: (2-)25-46-61 | | |
| 607-095-00-3 | maleic acid | | 203-742-5 | 110-16-7 | Xn; R22
Xi; R36/37/38
R43 | Xn
R: 22-36/37/38-43
S: (2-)24-26-28-37-46 | C ≥ 25 %: Xn; R22-36/37/38-43
20 % ≤ C <25 %: Xi; R36/37/38-43
0,1 % ≤ C < 20 %: Xi; R43 | |
| 607-103-00-5 | succinic anhydride | | 203-570-0 | 108-30-5 | Xn; R22
Xi; R36/37 | Xn
R: 22-36/37
S: (2-)25-46 | C ≥ 5 %: Xn; R22-36/37
1 % ≤ C < 5 %: Xi; R36/37 | |
| 607-142-00-8 | propyl chloroformate;
chloroformic acid propylester;
*n* -propyl chloroformate | | 203-687-7 | 109-61-5 | F; R11
T; R23
C; R34 | F; T
R: 11-23-34
S: (1/2-)16-26-36-45 | | |
| 607-195-00-7 | 2-methoxy-1-methylethyl acetate | | 203-603-9 | 108-65-6 | R10 | R: 10
S: (2-) | | |
| 607-216-00-X | glutamic acid, reaction products with *N* -(C 12-14 -alkyl)propylenediamine | | 403-950-8 | — | T+; R26
Xn; R22
C; R34
N; R50 | T+; N
R: 22-26-34-50
S: (1/2-)26-36/37/39-38-45-61 | | |
| 607-231-00-1 | clopyralid (ISO);
3,6-dichloropyridine-2-carboxylic acid | | 216-935-4 | 1702-17-6 | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 607-245-00-8 | *tert* -butyl acrylate | D | 216-768-7 | 1663-39-4 | F; R11
Xn; R20/21/22
Xi; R37/38
R43
N; R51-53 | F; Xn; N
R: 11-20/21/22-37/38-43-51/53
S: (2-)16-25-37-61 | C ≥ 25 %: Xn; R20/21/22-37/38-43-51/53
20 % ≤ C < 25 %: Xi; R37/38-43-52/53
2,5 % ≤ C < 20 %: Xi; R43-52/53
1 % ≤ C < 2,5 %: Xi; R43 | |
| 607-397-00-5 | A mixture of: Ca salicylates (branched C 10-14 and C 18-30 alkylated);
Ca phenates (branched C 10-14 and C 18-30 alkylated);
Ca sulfurised phenates (branched C 10-14 and C 18-30 alkylated) | | 415-930-6 | — | Repr. Cat. 3; R62
R43 | Xn
R: 43-62
S: (2-)23-36/37 | | |
| 608-005-00-5 | *n* -butyronitrile | | 203-700-6 | 109-74-0 | F; R11
T; R23/24/25 | F; T
R: 11-23/24/25
S: (1/2-)16-36/37-45-63 | | |
| 608-011-00-8 | oxalonitrile;
cyanogen | | 207-306-5 | 460-19-5 | F+; R12
T; R23
N; R50-53 | F+; T; N
R: 12-23-50/53
S: (1/2-)9-16-23-33-45-63-60-61 | | |
| 608-044-00-8 | 2-cyclohexylidene-2-phenylacetonitrile | | 423-740-1 | 10461-98-0 | Xn; R22
N; R51-53 | Xn; N
R; 22-51/53
S: (2-)46-61 | | |
| 609-007-00-9 | 2,4-dinitrotoluene; [1]
dinitrotoluene [2] | E | 204-450-0 [1]
246-836-1 [2] | 121-14-2 [1]
25321-14-6 [2] | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R23/24/25
Xn; R48/22
N; R50-53 | T; N
R: 45-23/24/25-48/22-62-68-50/53
S: 53-45-60-61 | | |
| 611-028-00-3 | *C,C* ′-azodi(formamide) | | 204-650-8 | 123-77-3 | E; R2
R42 | E; Xn
R: 2-42
S: (2-)22-24-37 | | |
| 611-035-00-1 | tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate | | 403-660-1 | 107246-80-0 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 612-044-00-3 | *N,N* ′-diacetylbenzidine | E | 210-338-2 | 613-35-4 | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R20/21/22 | T
R: 45-20/21/22-68
S: 53-45 | | |
| 612-050-00-6 | cyclohexylamine | | 203-629-0 | 108-91-8 | R10
Repr. Cat. 3; R62
Xn; R21/22
C; R34 | C
R: 10-21/22-34-62
S: (1/2-)26-36/37/39-45 | C ≥ 25 %: C; R21/22-34-62
10 % ≤ C < 25 %: C; R34-62
5 % ≤ C < 10 %: Xn; R36/38-62
2 % ≤ C < 5 %: Xi; R36/38 | |
| 612-076-00-8 | ethyldimethylamine | | 209-940-8 | 598-56-1 | F; R11
Xn; R20/22
C; R34 | F; C
R: 11-20/22-34
S: (1/2-)3-16-26-36-45 | | |
| 612-099-00-3 | 4-methyl- *m* -phenylenediamine;
2,4-toluenediamine | E | 202-453-1 | 95-80-7 | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
R43
N; R51-53 | T; N
R: 45-21-25-43-48/22-62-68-51/53
S: 53-45-61 | | |
| 612-101-00-2 | methenamine;
hexamethylenetetramine | | 202-905-8 | 100-97-0 | F; R11
R43 | F; Xi
R: 11-43
S: (2-)24-37 | | |
| 612-151-00-5 | methyl-phenylene diamine;
diaminotoluene;
[technical product - mixture of 4-methyl- *m* -phenylene diamine (EC No 202-453-1) and 2-methyl- *m* -phenylene diamine (EC No 212-513-9)] | E | — | — | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
T; R25
Xn; R21-48/22
Xi; R36
R43
N; R51-53 | T; N
R: 45-21-25-36-43-48/22-62-68-51/53
S: 53-45-61 | | |
| 612-237-00-2 | hydroxylammonium hydrogensulfate;
hydroxylamine sulfate(1:1); [1]
hydroxylamine phosphate; [2]
hydroxylamine dihydrogenphosphate; [3]
hydroxylamine 4-methylbenzenesulfonate [4] | T | 233-154-4 [1]
244-077-0 [2]
242-818-2 [3]
258-872-5 [4] | 10046-00-1 [1]
20845-01-6 [2]
19098-16-9 [3]
53933-48-5 [4] | E; R2
Carc. Cat. 3; R40
Xn; R21/22-48/22
Xi; R36/38
R43
N; R50 | E; Xn; N
R: 21/22-36/38-40-43-48/22-50
S: (2-)36/37-61 | | |
| 613-116-00-7 | tolylfluanid (ISO);
dichloro- *N* -[(dimethylamino)sulphonyl]fluoro- *N* -( *p* -tolyl)methanesulphenamide;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | 211-986-9 | 731-27-1 | T+; R26
T; R48/23
Xi; R36/37/38
R43
N; R50 | T+; N
R: 26-36/37/38-43-48/23-50
S: (1/2-)28-36/37/39-45-63-61 | C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-50
10 % ≤ C < 20 %: T+, N; R26-43-48/23-50
7 % ≤ C < 10 %: T+, N; R26-43-48/20-50
2,5 % ≤ C < 7 %: T, N; R23-43-48/20-50
1 % ≤ C < 2,5 %: T; R23-43-48/20
0,1 % ≤ C < 1 %: Xn; R20 | |
| 615-001-00-7 | methyl isocyanate | | 210-866-3 | 624-83-9 | F; R11
Repr. Cat. 3; R63
T+; R26
T; R24/25
R42/43
Xi; R37/38-41 | F; T+
R: 11-24/25-26-37/38-41-42/43-63
S: (1/2-)16-26-27/28-36/37/39-45-63 | | |
| 615-004-00-3 | salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22
R32
R52-53 | Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61 | | |
| 615-028-00-4 | ethyl 2-(isocyanatosulfonyl)benzoate | | 410-220-2 | 77375-79-2 | R14
Xn; R22-48/22
Xi; R41
R42/43 | Xn
R: 14-22-41-42/43-48/22
S: (2-)8-23-26-30-35-36/37/39 | | |
| 615-030-00-5 | alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22
R32
R52-53 | Xn
R: 20/21/22-32-52/53
S: (2-)13-36/37-46-61 | | |
| 615-031-00-0 | thallium thiocyanate | | 222-571-7 | 3535-84-0 | T+; R26/28
Xn; R21
R32
R33
N; R51-53 | T+; N
R: 21-26/28-32-33-51/53
S: (1/2-)13-28-36/37-45-61 | | |
| 615-032-00-6 | metal salts of thiocyanic acid, with the exception of those specified elsewhere in this Annex | A | — | — | Xn; R20/21/22
R32
N; R50-53 | Xn; N
R: 20/21/22-32-50/53
S: (2-)13-36/37-46-60-61 | | |
| 616-124-00-9 | lithium bis(trifluoromethylsulfonyl)imide | | 415-300-0 | 90076-65-6 | T; R24/25
Xn; R48/22
C; R34
R52-53 | T
R: 24/25-34-48/22-52/53
S: (1/2-)22-26-36/37/39-45-61 | | |
| 617-017-00-X | A mixture of: 2,2′-bis( *tert* -pentylperoxy)- *p* -diisopropylbenzene;
2,2′-bis( *tert* -pentylperoxy)- *m* -diisopropylbenzene | T | 412-140-3 | 32144-25-5 | E; R2
O; R7
R53 | E
R: 2-7-53
S: (2-)3/7-14-36/37/39-61 | | |
| 650-016-00-2 | Mineral wool, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na 2 O+K 2 O+CaO+MgO+BaO) content greater than 18 % by weight] | AQR | — | — | Carc. Cat. 3; R40 | Xn
R: 40
S: (2-)36/37 | | |
| 650-017-00-8 | Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;
[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na 2 O+K 2 O+CaO+ MgO+BaO) content less or equal to 18 % by weight] | AR | — | — | Carc. Cat. 2; R49 | T
R: 49
S: 53-45 | | |
| Index No | Chemical name | Notes related to substances | EC No | CAS No | Classification | Labelling | Concentration Limits | Notes related to preparations |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 003-003-00-5 | (2-methylpropyl)lithium;
isobutyllithium | | 440-620-2 | 920-36-5 | F; R15-17
R14
C; R35
R67
N; R50-53 | F; C; N
R: 14/15-17-35-67-50/53
S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61 | | |
| 005-013-00-5 | diethylmethoxyborane | | 425-380-9 | 7397-46-8 | F; R17
Xn; R20/21/22-48/22
C; R34
R43
R53 | F; C
R: 17-20/21/22-34-43-48/22-53
S: (1/2-)6-26-36/37/39-43-45-61 | | |
| 005-014-00-0 | 4-formylphenylboronic acid | | 438-670-5 | 87199-17-5 | R43 | Xi
R: 43
S: (2-)24-37 | | |
| 005-017-00-7 | sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | 239-172-9 [1]
234-390-0 [2]
- [3]
231-556-4 [4]
- [5] | 15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5] | O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R22
Xi; R37-41 | O; T
R: 61-8-22-37-41-62
S: 53-45 | C ≥ 25 %: T; R61-22-37-41-62
22 % ≤ C < 25 %: T; R61-37-41-62
20 % ≤ C < 22 %: T; R61-36/37-62
14 % ≤ C < 20 %: T; R61-36-62
9 % ≤ C < 14 %: T; R61-62
6,5 % ≤ C < 9 %: T; R61 | |
| 005-017-01-4 | sodium perborate; [1]
perboric acid, sodium salt; [2]
perboric acid, sodium salt, monohydrate; [3]
sodium peroxometaborate; [4]
perboric acid (HBO(O2)), sodium salt, monohydrate; [5]
sodium peroxoborate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | 239-172-9 [1]
234-390-0 [2]
- [3]
231-556-4 [4]
- [5] | 15120-21-5 [1]
11138-47-9 [2]
12040-72-1 [3]
7632-04-4 [4]
10332-33-9 [5] | O; R8
Repr. Cat. 2; R61
Repr. Cat. 3; R62
T; R23
Xn; R22
Xi; R37-41 | O; T
R: 61-8-22-23-37-41-62
S: 53-45 | C ≥ 25 %: T; R61-22-23-37-41-62
22 % ≤ C < 25 %: T; R61-20-37-41-62
20 % ≤ C < 22 %: T; R61-20-36/37-62
14 % ≤ C < 20 %: T; R61-20-36-62
9 % ≤ C < 14 %: T; R61-20-62
6,5 % ≤ C < 9 %: T; R61-20
3 % ≤ C < 6,5 %: Xn; R20 | |
| 005-018-00-2 | perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | - [1]
- [2]
- [3] | 13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3] | Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xi; R37-41 | T
R: 61-37-41-62
S: 53-45-47 | C ≥ 36 %: T; R61-37-41-62
22 % ≤ C < 36 %: T; R61-36/37-62
20 % ≤ C < 22 %: T; R61-37-62
14 % ≤ C < 20 %: T; R61-62
10 % ≤ C < 14 %: T; R61 | |
| 005-018-01-X | perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]
perboric acid, sodium salt, tetrahydrate; [2]
perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]
sodium peroxoborate hexahydrate;
[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | E | - [1]
- [2]
- [3] | 13517-20-9 [1]
37244-98-7 [2]
10486-00-7 [3] | Repr. Cat. 2; R61
Repr. Cat. 3; R62
Xn; R20
Xi; R37-41 | T
R: 61-20-37-41-62
S: 53-45-47 | C ≥ 36 %: T; R61-20-37-41-62
25 % ≤ C < 36 %: T; R61-20-36/37-62
22 % ≤ C < 25 %: T; R61-36/37-62
20 % ≤ C < 22 %: T; R61-37-62
14 % ≤ C < 20 %: T; R61-62
10 % ≤ C < 14 %: T; R61 | |
| 006-097-00-6 | 1-phenyl-3-( *p* -toluenesulfonyl)urea | | 424-620-1 | 13909-63-2 | Xn; R22-48/22
R52-53 | Xn
R: 22-48/22-52/53
S: (2-)22-36-61 | | |
| 006-098-00-1 | *tert* -butyl (1 *R* ,5 *S* )-3-azabicyclo[3.1.0]hex-6-ylcarbamate | | 429-170-8 | 134575-17-0 | Xn; R22-48/22
Xi; R41
R43 | Xn
R: 22-41-43-48/22
S: (2-)22-26-36/37/39 | | |
| 006-099-00-7 | *N* -( *p* -toluenesulfonyl)- *N′* -(3-( *p* -toluenesulfonyloxy)phenyl)urea;
3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate | | 432-520-2 | 232938-43-1 | N; R51-53 | N
R: 51/53
S: 22-61 | | |
| 006-101-00-6 | mixture of: *N,N″* -(methylenedi-4,1-phenylene)bis[ *N′* -phenylurea];
*N* -(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]- *N′* -cyclohexylurea;
*N,N″* -(methylenedi-4,1-phenylene)bis[ *N′* -cyclohexylurea] | | 423-070-8 | — | R53 | R: 53
S: 61 | | |
| 006-102-00-1 | *O* -hexyl- *N* -ethoxycarbonylthiocarbamate | E | 432-750-3 | — | Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R22-48/22
R43
N; R51-53 | T; N
R: 45-46-22-43-48/22-51/53
S: 53-45-61 | | |
| 006-103-00-7 | *N,N″* -(methylenedi-4,1-phenylene)bis[ *N′* -octyl]urea | | 445-760-8 | — | Xi; R41
R42
N; R50-53 | Xn; N
R: 41-42-50/53
S: (2-)22-26-39-45-60-61 | C ≥10 %: Xn, N; R41-42-50/53
5 % ≤ C < 10 %: Xn, N; R36-42-50/53
1 % ≤ C < 5 %: Xn, N; R42-50/53
0,25 % ≤ C < 1 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 ≤ C < 0,025 %: R52/53 | |
| 007-029-00-8 | diethyldimethylammonium hydroxide | | 419-400-5 | 95500-19-9 | Xn; R21/22
C; R35 | C
R: 21/22-35
S: (1/2-)26-36/37/39-45 | | |
| 012-004-00-X | aluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate | | 422-150-1 | — | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 014-036-00-X | (4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane | | 405-020-7 | 105024-66-6 | Repr.Cat.2; R60
N; R50-53 | T; N
R: 60-50/53
S: 53-45-60-61 | C ≥ 0,5 %: T, N; R60-50/53
0,025 % ≤ C < 0,5 %: N; R50/53
0,0025 % ≤ C < 0,025 %: N; R51/53
0,00025 % ≤ C < 0,0025 %: R52/53 | |
| 014-037-00-5 | 2-butanone- *O,O′,O′* ′-(phenylsilylidyne)trioxime | | 433-360-6 | 34036-80-1 | Xn; R48/22
R43
R52-53 | Xn
R: 43-48/22-52/53
S: (2-)36/37-61 | | |
| 014-038-00-0 | *S* -(3-(triethoxysilyl)propyl)octanethioate | | 436-690-9 | 220727-26-4 | R43 | Xi
R: 43
S: (2-)24-37 | | |
| 014-039-00-6 | (2,3-dimethylbut-2-yl)-trimethoxysilane | | 439-360-2 | 142877-45-0 | Xi; R38-41
R52-53 | Xi
R: 38-41-52/53
S: (2-)26-37/39-61 | | |
| 014-041-00-7 | *N,N* -bis(trimethylsilyl)aminopropylmethyldiethoxysilane | | 445-890-5 | 201290-01-9 | Xn; R22
R43 | Xn
R: 22-43
S: (2-)24-37 | | |
| 014-042-00-2 | mixture of: *O,O′,O″,O′′′* -silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers) | | 423-010-0 | — | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 014-043-00-8 | reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %) | | 432-200-2 | — | F; R11
Xi; R37/38-41
R52-53 | F; Xi
R: 11-37/38-41-52/53
S: (2-)6-26-36/39-61 | | |
| 014-044-00-3 | 3-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane | | 433-050-0 | — | N; R51-53 | N
R: 51/53
S: 61 | | |
| 014-045-00-9 | magnesium sodium fluoride silicate | | 442-650-1 | — | Xn; R48/20 | Xn
R: 48/20
S: (2-)22-36 | | |
| 015-190-00-0 | bis(2,4-dicumylphenyl) neopentyl diphosphite;
3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane | | 421-920-2 | 154862-43-8 | R53 | R: 53
S: 61 | | |
| 015-191-00-6 | dodecyldiphenyl phosphate | | 431-760-5 | 27460-02-2 | Xi; R38
R52-53 | Xi
R: 38-52/53
S: (2-)37-61 | | |
| 015-192-00-1 | tetrakis(2,6-dimethylphenyl)- *m* -phenylene biphosphate | | 432-770-2 | 139189-30-3 | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 015-193-00-7 | triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro- *N* -methyl-1-butanesulfonamide (1:1) | | 442-960-7 | 332350-93-3 | T; R25
Xi; R41
N; R50-53 | T; N
R: 25-41-50/53
S: (1/2-)26-39-45-60-61 | | |
| 015-194-00-2 | tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate | | 444-440-5 | 220689-12-3 | Xn; R22
R52-53 | Xn
R: 22-52/53
S: (2-)61 | | |
| 015-195-00-8 | mixture of: potassium *o* -toluenephosphonate;
potassium *m* -toluenephosphonate;
potassium *p* -toluenephosphonate | | 433-860-4 | — | Xi; R36
R43
R52-53 | Xi
R: 36-43-52/53
S: (2-)24-26-37-61 | | |
| 015-196-00-3 | mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;
methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate | | 435-960-3 | — | Carc.Cat.2; R45
Muta.Cat.2; R46
R43 | T
R: 45-46-43
S: 53-45 | | |
| 015-197-00-9 | bis(2,4,4-trimethylpentyl)dithiophosphonic acid | | 420-160-9 | 107667-02-7 | R10
T; R23
Xn; R22
C; R34
N; R51-53 | T; N
R: 10-22-23-34-51/53
S: (1/2-)9-26-36/37/39-45-61 | | |
| 015-198-00-4 | (4-phenylbutyl)phosphinic acid | | 420-450-5 | 86552-32-1 | Carc.Cat.3; R40
Xi; R41 | Xn
R: 40-41
S: (2-)23-26-36/37/39 | | |
| 016-094-00-1 | sulfur | | 231-722-6 | 7704-34-9 | Xi; R38 | Xi
R: 38
S: (2-)46 | | |
| 016-097-00-8 | 1-amino-2-methyl-2-propanethiol hydrochloride | | 434-480-1 | 32047-53-3 | Xn; R22
C; R34
R43
R52-53 | C
R: 22-34-43-52/53
S: (1/2-)22-26-36/37/39-45-61 | | |
| 017-009-01-8 | ammonium perchlorate;
[containing < 80 % of 0-30 μm particles] | T | 232-235-1 | 7790-98-9 | E; R2
O; R9 | E
R: 2-9
S: (2-)14-16-36/37 | | |
| 022-004-00-1 | potassium titanium oxide (K 2 Ti 6 O 13 ) | | 432-240-0 | 12056-51-8 | Carc.Cat.3; R40 | Xn
R: 40
S: (2-)22-36/37 | | |
| 022-005-00-7 | [ *N* -(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κ *N* ][(1,2,3,4-η)-1,3-pentadiene]-titanium | | 419-840-8 | 169104-71-6 | F; R11
C; R34
R43
R53 | F; C
R: 11-34-43-53
S: (1/2-)6-9-16-26-36/37/39-45-61 | | |
| 028-002-01-4 | nickel powder;
[particle diameter < 1 mm] | | 231-111-4 | 7440-02-0 | Carc. Cat. 3; R40
T; R48/23
R43
R52-53 | T
R: 40-43-48/23-52/53
S: (2-)36/37/39-45-61 | | |
| 028-013-00-7 | nickel matte | E, H | 273-749-6 | 69012-50-6 | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-014-00-2 | slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate | E | 295-859-3 | 92129-57-2 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
Xi; R38
R42/43
N; R50-53 | T; N
R: 49-61-20/22-38-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/53
20 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/53
2,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-015-00-8 | slimes and sludges, copper electrolyte refining, decopperised | E, H | 305-433-1 | 94551-87-8 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 1; R61
Repr. Cat. 3; R62
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-62-68-50/53
S: 53-45-60-61 | | |
| 028-016-00-3 | nickel diperchlorate;
perchloric acid, nickel(II) salt | E, H | 237-124-1 | 13637-71-3 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
C; R34
R42/43
N; R50-53 | T; N
R: 49-61-34-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/53
5 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/53
2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-017-00-9 | nickel dipotassium bis(sulfate); [1]
diammonium nickel bis(sulfate) [2] | E, H | 237-563-9 [1]
239-793-2 [2] | 13842-46-1 [1]
15699-18-0 [2] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53 | T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-018-00-4 | nickel bis(sulfamidate);
nickel sulfamate | E, H | 237-396-1 | 13770-89-3 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-019-00-X | nickel bis(tetrafluoroborate) | E, H | 238-753-4 | 14708-14-6 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-021-00-0 | nickel diformate; [1]
formic acid, nickel salt; [2]
formic acid, copper nickel salt [3] | E, H | 222-101-0 [1]
239-946-6 [2]
268-755-0 [3] | 3349-06-2 [1]
15843-02-4 [2]
68134-59-8 [3] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C 0,1 %: Xi; R43 | |
| 028-022-00-6 | nickel di(acetate); [1]
nickel acetate [2] | E, H | 206-761-7 [1]
239-086-1 [2] | 373-02-4 [1]
14998-37-9 [2] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
Xn; R20/22
R42/43
N; R50-53 | T; N
R: 49-61-20/22-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-024-00-7 | nickel dibenzoate | E, H | 209-046-8 | 553-71-9 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-025-00-2 | nickel bis(4-cyclohexylbutyrate) | E, H | 223-463-2 | 3906-55-6 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-026-00-8 | nickel(II) stearate;
nickel(II) octadecanoate | E, H | 218-744-1 | 2223-95-2 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-027-00-3 | nickel dilactate | E, H | — | 16039-61-5 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-028-00-9 | nickel(II) octanoate | E, H | 225-656-7 | 4995-91-9 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat 2; R61
T; R48/23
C; R35
R42/43
N; R50-53 | T; C; N
R: 49-61-35-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/53
10 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/53
5 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/53
2,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-029-00-4 | nickel difluoride; [1]
nickel dibromide; [2]
nickel diiodide; [3]
nickel potassium fluoride [4] | E, H | 233-071-3 [1]
236-665-0 [2]
236-666-6 [3]
- [4] | 10028-18-9 [1]
13462-88-9 [2]
13462-90-3 [3]
11132-10-8 [4] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-030-00-X | nickel hexafluorosilicate | E, H | 247-430-7 | 26043-11-8 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-031-00-5 | nickel selenate | E, H | 239-125-2 | 15060-62-5 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-032-00-0 | nickel hydrogen phosphate; [1]
nickel bis(dihydrogen phosphate); [2]
trinickel bis(orthophosphate); [3]
dinickel diphosphate; [4]
nickel bis(phosphinate); [5]
nickel phosphinate; [6]
phosphoric acid, calcium nickel salt; [7]
diphosphoric acid, nickel(II) salt [8] | E, H | 238-278-2 [1]
242-522-3 [2]
233-844-5 [3]
238-426-6 [4]
238-511-8 [5]
252-840-4 [6]
- [7]
- [8] | 14332-34-4 [1]
18718-11-1 [2]
10381-36-9 [3]
14448-18-1 [4]
14507-36-9 [5]
36026-88-7 [6]
17169-61-8 [7]
19372-20-4 [8] | Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61 | | |
| 028-033-00-6 | diammonium nickel hexacyanoferrate | E, H | — | 74195-78-1 | Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61 | | |
| 028-034-00-1 | nickel dicyanide | E, H | 209-160-8 | 557-19-7 | Carc. Cat. 1; R49
T; R48/23
R42/43
R32
N; R50-53 | T; N
R: 49-32-42/43-48/23-50/53
S: 53-45-60-61 | | |
| 028-035-00-7 | nickel chromate | E, H | 238-766-5 | 14721-18-7 | Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61 | | |
| 028-036-00-2 | nickel(II) silicate; [1]
dinickel orthosilicate; [2]
nickel silicate (3:4); [3]
silicic acid, nickel salt; [4]
trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5] | E, H | 244-578-4 [1]
237-411-1 [2]
250-788-7 [3]
253-461-7 [4]
235-688-3 [5] | 21784-78-1 [1]
13775-54-7 [2]
31748-25-1 [3]
37321-15-6 [4]
12519-85-6 [5] | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-037-00-8 | dinickel hexacyanoferrate | E, H | 238-946-3 | 14874-78-3 | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-038-00-3 | trinickel bis(arsenate);
nickel(II) arsenate | E, H | 236-771-7 | 13477-70-8 | Carc. Cat. 1; R45
T; R48/23
R43
N; R50-53 | T; N
R: 45-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-039-00-9 | nickel oxalate; [1]
oxalic acid, nickel salt [2] | E, H | 208-933-7 [1]
243-867-2 [2] | 547-67-1 [1]
20543-06-0 [2] | Carc. Cat. 1; R49
T; R48/23
R43
N: R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-040-00-4 | nickel telluride | E, H | 235-260-6 | 12142-88-0 | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-041-00-X | trinickel tetrasulfide | E, H | — | 12137-12-1 | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-042-00-5 | trinickel bis(arsenite) | E, H | — | 74646-29-0 | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-043-00-0 | cobalt nickel gray periclase;
C.I. Pigment Black 25;
C.I. 77332; [1]
cobalt nickel dioxide; [2]
cobalt nickel oxide [3] | E, H | 269-051-6 [1]
261-346-8 [2]
- [3] | 68186-89-0 [1]
58591-45-0 [2]
12737-30-3 [3] | Carc. Cat. 1; R49
T; R48/23
R43 | T
R: 49-43-48/23
S: 53-45 | | |
| 028-044-00-6 | nickel tin trioxide;
nickel stannate | E, H | 234-824-9 | 12035-38-0 | Carc. Cat. 1; R49
T; R48/23
R43 | T
R: 49-43-48/23
S: 53-45 | | |
| 028-045-00-1 | nickel triuranium decaoxide | E, H | 239-876-6 | 15780-33-3 | Carc. Cat. 1; R49
T; R48/23
R43 | T
R: 49-43-48/23
S: 53-45 | | |
| 028-046-00-7 | nickel dithiocyanate | E, H | 237-205-1 | 13689-92-4 | Carc. Cat. 1; R49
Muta. Cat. 3;R68
Repr. Cat. 2; R61
T; R48/23
R42/43
R32
N; R50-53 | T; N
R: 49-61-32-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-047-00-2 | nickel dichromate | E, H | 239-646-5 | 15586-38-6 | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1% ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C 0,1 %: Xi; R43 | |
| 028-048-00-8 | nickel(II) selenite | E, H | 233-263-7 | 10101-96-9 | Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61 | | |
| 028-049-00-3 | nickel selenide | E, H | 215-216-2 | 1314-05-2 | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-050-00-9 | silicic acid, lead nickel salt | E, H | — | 68130-19-8 | Carc. Cat. 1: R49
Repr. Cat. 1: R61
Repr. Cat. 3; R62
T; R48/23
R43
N; R50-53 | T; N
R: 49-61-43-48/23-62-50/53
S: 53-45-60-61 | | |
| 028-051-00-4 | nickel diarsenide; [1]
nickel arsenide [2] | E, H | 235-103-1 [1]
248-169-1 [2] | 12068-61-0 [1]
27016-75-7 [2] | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-052-00-X | nickel barium titanium primrose priderite;
C.I. Pigment Yellow 157;
C.I. 77900 | E, H | 271-853-6 | 68610-24-2 | Carc. Cat. 1: R49
T; R48/23
R43 | T
R: 49-43-48/23
S: 53-45 | | |
| 028-053-00-5 | nickel dichlorate; [1]
nickel dibromate; [2]
ethyl hydrogen sulfate, nickel(II) salt [3] | E, H | 267-897-0 [1]
238-596-1 [2]
275-897-7 [3] | 67952-43-6 [1]
14550-87-9 [2]
71720-48-4 [3] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T: R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-054-00-0 | nickel(II) trifluoroacetate; [1]
nickel(II) propionate; [2]
nickel bis(benzenesulfonate); [3]
nickel(II) hydrogen citrate; [4]
citric acid, ammonium nickel salt; [5]
citric acid, nickel salt; [6]
nickel bis(2-ethylhexanoate); [7]
2-ethylhexanoic acid, nickel salt; [8]
dimethylhexanoic acid nickel salt; [9]
nickel(II) isooctanoate; [10]
nickel isooctanoate; [11]
nickel bis(isononanoate); [12]
nickel(II) neononanoate; [13]
nickel(II) isodecanoate; [14]
nickel(II) neodecanoate; [15]
neodecanoic acid, nickel salt; [16]
nickel(II) neoundecanoate; [17]
bis(D-gluconato- *O* 1 , *O* 2 )nickel; [18]
nickel 3,5-bis( *tert* -butyl)-4-hydroxybenzoate (1:2); [19]
nickel(II) palmitate; [20]
(2-ethylhexanoato- *O* )(isononanoato- *O* )nickel; [21]
(isononanoato- *O* )(isooctanoato- *O* )nickel; [22]
(isooctanoato- *O* )(neodecanoato- *O* )nickel; [23]
(2-ethylhexanoato- *O* )(isodecanoato- *O* )nickel; [24]
(2-ethylhexanoato- *O* )(neodecanoato- *O* )nickel; [25]
(isodecanoato- *O* )(isooctanoato- *O* )nickel; [26]
(isodecanoato- *O* )(isononanoato- *O* )nickel; [27]
(isononanoato- *O* )(neodecanoato- *O* )nickel; [28]
fatty acids, C 6-19 -branched, nickel salts; [29]
fatty acids, C 8-18 and C 18 -unsaturated, nickel salts; [30]
2,7-naphthalenedisulfonic acid, nickel(II) salt; [31] | E, H | 240-235-8 [1]
222-102-6 [2]
254-642-3 [3]
242-533-3 [4]
242-161-1 [5]
245-119-0 [6]
224-699-9 [7]
231-480-1 [8]
301-323-2 [9]
249-555-2 [10]
248-585-3 [11]
284-349-6 [12]
300-094-6 [13]
287-468-1 [14]
287-469-7 [15]
257-447-1 [16]
300-093-0 [17]
276-205-6 [18]
258-051-1 [19]
237-138-8 [20]
287-470-2 [21]
287-471-8 [22]
284-347-5 [23]
284-351-7 [24]
285-698-7 [25]
285-909-2 [26]
284-348-0 [27]
287-592-6 [28]
294-302-1 [29]
283-972-0 [30]
- [31] | 16083-14-0 [1]
3349-08-4 [2]
39819-65-3 [3]
18721-51-2 [4]
18283-82-4 [5]
22605-92-1 [6]
4454-16-4 [7]
7580-31-6 [8]
93983-68-7 [9]
29317-63-3 [10]
27637-46-3 [11]
84852-37-9 [12]
93920-10-6 [13]
85508-43-6 [14]
85508-44-7 [15]
51818-56-5 [16]
93920-09-3 [17]
71957-07-8 [18]
52625-25-9 [19]
13654-40-5 [20]
85508-45-8 [21]
85508-46-9 [22]
84852-35-7 [23]
84852-39-1 [24]
85135-77-9 [25]
85166-19-4 [26]
84852-36-8 [27]
85551-28-6 [28]
91697-41-5 [29]
84776-45-4 [30]
72319-19-8 [31] | Carc. Cat. 1; R49
Muta. Cat. 3; R68
Repr. Cat. 2; R61
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-61-42/43-48/23-68-50/53
S: 53-45-60-61 | C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/53
2,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/53
1 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/53
0,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/53
0,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/53
0,1 % ≤ C < 0,25 %: T; R49-43-48/20
0,01 % ≤ C < 0,1 %: Xi; R43 | |
| 028-055-00-6 | nickel(II) sulfite; [1]
nickel tellurium trioxide; [2]
nickel tellurium tetraoxide; [3]
molybdenum nickel hydroxide oxide phosphate [4] | E, H | 231-827-7 [1]
239-967-0 [2]
239-974-9 [3]
268-585-7 [4] | 7757-95-1 [1]
15851-52-2 [2]
15852-21-8 [3]
68130-36-9 [4] | Carc. Cat. 1; R49
T; R48/23
R42/43
N; R50-53 | T; N
R: 49-42/43-48/23-50/53
S: 53-45-60-61 | | |
| 028-056-00-1 | nickel boride (NiB); [1]
dinickel boride; [2]
trinickel boride; [3]
nickel boride; [4]
dinickel silicide; [5]
nickel disilicide; [6]
dinickel phosphide; [7]
nickel boron phosphide [8] | E, H | 234-493-0 [1]
234-494-6 [2]
234-495-1 [3]
235-723-2 [4]
235-033-1 [5]
235-379-3 [6]
234-828-0 [7]
- [8] | 12007-00-0 [1]
12007-01-1 [2]
12007-02-2 [3]
12619-90-8 [4]
12059-14-2 [5]
12201-89-7 [6]
12035-64-2 [7]
65229-23-4 [8] | Carc. Cat. 1; R49
T; R48/23
R43
N; R50-53 | T; N
R: 49-43-48/23-50/53
S: 53-45-60-61 | | |
| 028-057-00-7 | dialuminium nickel tetraoxide; [1]
nickel titanium trioxide; [2]
nickel titanium oxide; [3]
nickel divanadium hexaoxide; [4]
cobalt dimolybdenum nickel octaoxide; [5]
nickel zirkonium trioxide; [6]
molybdenum nickel tetraoxide; [7]
nickel tungsten tetraoxide; [8]
olivine, nickel green; [9]
lithium nickel dioxide; [10]
molybdenum nickel oxide; [11] | E, H | 234-454-8 [1]
234-825-4 [2]
235-752-0 [3]
257-970-5 [4]
268-169-5 [5]
274-755-1 [6]
238-034-5 [7]
238-032-4 [8]
271-112-7 [9]
- [10]
- [11] | 12004-35-2 [1]
12035-39-1 [2]
12653-76-8 [3]
52502-12-2 [4]
68016-03-5 [5]
70692-93-2 [6]
14177-55-0 [7]
14177-51-6 [8]
68515-84-4 [9]
12031-65-1 [10]
12673-58-4 [11] | Carc. Cat. 1; R49
T; R48/23
R43 | T
R: 49-43-48/23
S: 53-45 | | |
| 028-058-00-2 | cobalt lithium nickel oxide | E | 442-750-5 | — | Carc. Cat. 1; R49
T+; R26
T; R48/23
R43
N; R50-53 | T+; N
R: 49-26-43-48/23-50/53
S: 53-45-60-61 | | |
| 029-014-00-5 | mixture of: 2,2′-[[ *cis* -1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-) *N,N′,O,O′* -copper complex;
2,2′-[[ *trans* -1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-) *N,N′,O,O′* -copper complex | | 419-610-7 | 171866-24-3 | Xn; R48/22
N; R51-53 | Xn; N
R: 48/22-51/53
S: (2-)22-36-61 | | |
| 030-012-00-1 | aluminium-magnesium-zinc-carbonate-hydroxide | | 423-570-6 | 169314-88-9 | R52-53 | R: 52/53
S: 61 | | |
| 030-015-00-8 | tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate | | 440-060-9 | — | N; R51-53 | N
R: 51/53
S: 61 | | |
| 042-005-00-0 | mixture of: mono- and di-glycerols of canola oil;
canola oil acid amide of branched 1,3-propanediamine, *N* -[3-(tridecyloxy)-propyl];
*N,N* -diorgano dithiocarbamate molybdenum complex | | 434-240-6 | — | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)24-37-61 | | |
| 050-023-00-5 | mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;
bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;
bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;
((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane | | 422-920-5 | — | Xn; R48/22
N; R50-53 | Xn; N
R: 48/22-50/53
S: (2-)23-36-60-61 | C ≥ 10 %: Xn, N; R48/22-50/53
2,5 % ≤ C < 10 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 050-024-00-0 | mixture of: tri- *p* -tolyltin hydroxide;
hexa- *p* -tolyl-distannoxane | | 432-230-6 | — | T; R48/25
Xn; R22
Xi; R38-41
R43
N; R50-53 | T; N
R: 22-38-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61 | | |
| 064-001-00-8 | gadolinium(III)sulfite trihydrate | | 456-900-2 | 51285-81-5 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 078-011-00-5 | hydroxydisulfito platinum(II) acid | | 423-310-1 | 61420-92-6 | Xn; R22-48/20/21/22
C; R35
R42/43
R52-53 | C
R: 22-35-42/43-48/20/21/22-52/53
S: (1/2-)23-24-26-28-36/37/39-45-61 | | |
| 078-012-00-0 | platinum(IV) nitrate/nitric acid solution | | 432-400-1 | — | C; R35
N; R50-53 | C; N
R: 35-50/53
S: (1/2-)26-36/37/39-45-60-61 | | |
| 082-012-00-6 | barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped | | 431-780-4 | 199876-46-5 | Xn; R22-48/22
N; R51-53 | Xn; N
R: 22-48/22-51/53
S: (2-)22-36-61 | | |
| 601-080-00-5 | mixture of: *sec* -butylphenyl(phenyl)methane, mixed isomers;
1-( *sec* -butylphenyl(phenyl)-2-phenylethane, mixed isomers;
1-( *sec* -butylphenyl-1-phenylethane, mixed isomers | | 431-100-6 | — | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 601-081-00-0 | cyclohexadeca-1,9-diene | | 431-730-1 | 4277-06-9 | Xi; R38
R43
R53 | Xi
R: 38-43-53
S: (2-)36/37-61 | | |
| 601-082-00-6 | mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;
exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane | | 434-420-4 | — | Xi; R38-41
N; R50-53 | Xi; N
R: 38-41-50/53
S: (2-)23-26-37/39-57-60-61 | | |
| 601-083-00-1 | 5-endo-hexyl-bicyclo[2.2.1]hept-2-ene | | 435-000-3 | 22094-83-3 | Xn; R65
Xi; R38
R53 | Xn
R: 38-65-53
S: (2-)37-62-61 | | |
| 601-084-00-7 | mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;
5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20) | | 435-180-3 | — | Xn; R65
Xi; R38
N; R50-53 | Xn; N
R: 38-65-50/53
S: (2-)37-62-60-61 | | |
| 602-105-00-2 | sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate | | 422-100-7 | 102061-82-5 | Xi; R41
R43 | Xi
R: 41-43
S: (2-)24-26-37/39 | | |
| 602-106-00-8 | 2-bromo-4,6-difluoroaniline | | 429-430-0 | 444-14-4 | Xn; R22
N; R51-53 | Xn; N
R: 22-51/53
S: (2-)25-61 | | |
| 602-107-00-3 | 3,3,4,4-tetrafluoro-4-iodo-1-butene | | 439-500-2 | 33831-83-3 | Xn; R22
Xi; R38
N; R51-53 | Xn; N
R: 22-38-51/53
S: (2-)37-61 | | |
| 602-108-00-9 | (2,3,5,6-tetrafluorophenyl)methanol | | 443-840-7 | 4084-38-2 | Xn; R22
Xi; R36
R43 | Xn
R: 22-36-43
S: (2-)26-36/37 | | |
| 603-211-00-1 | 2,3-epoxypropyltrimethylammonium chloride … %;
glycidyl trimethylammonium chloride … % | B E | 221-221-0 | 3033-77-0 | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62
Xn; R21/22-48/22
Xi; R41
R43
R52-53 | T
R: 45-21/22-41-43-48/22-62-68-52/53
S: 53-45-61 | | |
| 603-212-00-7 | 1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6- *c* ]pyran;
galaxolide;
(HHCB) | | 214-946-9 | 1222-05-5 | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 603-213-00-2 | 2-methoxy-2-methylbutane;
*tert* -amyl methyl ether | | 213-611-4 | 994-05-8 | F; R11
Xn; R22
R67 | F; Xn
R: 11-22-67
S: (2-)9-16-23-33 | | |
| 603-214-00-8 | 1,1-diisopropoxycyclohexane | | 413-740-8 | 1132-95-2 | C; R34 | C
R: 34
S: (1/2-)23-26-36/37/39-45 | | |
| 603-215-00-3 | 1-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate) | | 418-330-2 | 162241-33-0 | E; R2
Xn; R22-48/22
Xi; R41
R43
N; R50-53 | E; Xn; N
R: 2-22-41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61 | | |
| 603-216-00-9 | *cis* -1-amino-2,3-dihydro-1 *H* -inden-2-ol | | 422-660-2 | 7480-35-5 | Xi; R41
R43
R52-53 | Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 | | |
| 603-217-00-4 | 2,4,6-tri- *tert* -butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite | | 423-560-1 | 161717-32-4 | R43
R53 | Xi
R: 43-53
S: (2-)24-37/39-61 | | |
| 603-220-00-0 | 1-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9 *H* -carbazol-4-yloxy)propan-2-ol | | 432-890-5 | 72955-94-3 | R53 | R: 53
S: 61 | | |
| 603-221-00-6 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)] | | 433-580-2 | 214353-17-0 | Xn; R22
C; R34
N; R51-53 | C; N
R: 22-34-51/53
S: (1/2-)26-36/37/39-45-61 | | |
| 603-221-01-3 | 1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;
[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)] | E | 433-580-2 | 214353-17-0 | Carc. Cat. 2; R45
Xn; R22
C; R34
N; R51-53 | T; N
R: 45-22-34-51/53
S: 53-45-61 | | |
| 603-222-00-1 | (2 *R* ,3 *S* ,4 *R* ,5 *R* ,7 *R* ,9 *R* ,10 *R* ,11 *S* ,12 *S* ,13 *R* )-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane | | 433-820-6 | 118058-74-5 | Xi; R36 | Xi
R: 36
S: (2-)26 | | |
| 603-223-00-7 | 2-cyclopentylidene cyclopentanol;
1,1′-bi(cyclopentyliden)-2-ol | | 434-270-1 | 6261-30-9 | Xi; R38-41
R52-53 | Xi
R: 38-41-52/53
S: (2-)26-37/39-61 | | |
| 603-224-00-2 | 3-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane | | 435-790-1 | 297730-93-9 | R53 | R: 53
S: 61 | | |
| 603-225-00-8 | erythromycin A9-oxime (E);
(3 *R* ,4 *S* ,5 *S* ,6 *R* ,7 *R* ,9 *R* ,11 *R* ,12 *R* ,13 *S* ,14 *R* )-4-((2,6-didesoxy-3- *C* -methyl-3- *O* -methyl-α- *L* -ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E) | | 437-070-0 | 13127-18-9 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 603-226-00-3 | 4,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol | | 444-500-0 | 1440-00-2 | R52-53 | R: 52/53
S: 61 | | |
| 603-227-00-9 | α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);
reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate | | 445-060-2 | 203574-04-3 | O; R7
N; R50-53 | O; N
R: 7-50/53
S: (2-)3/7-14-36/37/39-60-61 | | |
| 603-228-00-4 | (+/-)-( *R*,R** )-6-fluoro-3,4-dihydro-2-oxiranyl-2 *H* -1-benzopyran;
6-fluoro-2-(2-oxiranyl)chromane | | 419-620-1 | — | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)36/37-61 | | |
| 603-229-00-X | sodium ( *Z* )-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate | | 420-800-7 | — | Xi; R38-41
R43
N; R50-53 | Xi; N
R: 38-41-43-50/53
S: (2-)24-26-37/39-60-61 | | |
| 603-230-00-5 | 2,6,6,7,8,8-hexamethyldecahydro-2 *H* -indeno[4,5-b]furan | | 440-030-5 | — | Xi; R38-41
R53 | Xi
R: 38-41-53
S: (2-)26-37/39-61 | | |
| 603-231-00-0 | ( *S* )-1,1-diphenyl-1,2-propanediol | | 443-220-6 | — | R52-53 | R: 52/53
S: 22-61 | | |
| 603-232-00-6 | 3,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane | | 444-420-6 | — | R53 | R: 53
S: 61 | | |
| 603-233-00-1 | mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;
1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;
( *E* )-4-(3a,4,5,6,7,7a-hexahydro-1 *H* -4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;
( *E* )-4-(3a,4,5,6,7,7a-hexahydro-3 *H* -4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol | | 444-430-0 | — | N; R51-53 | N
R: 51/53
S: 61 | | |
| 603-234-00-7 | (1 *R* ,4 *R* )-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene | | 444-480-3 | — | Xi; R38
N; R51-53 | Xi; N
R: 38-51/53
S: (2-)37-61 | | |
| 604-074-00-0 | tetrabromobisphenol-A;
2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol | | 201-236-9 | 79-94-7 | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 604-075-00-6 | 4-(1,1,3,3-tetramethylbutyl)phenol;
4- *tert* -octylphenol | | 205-426-2 | 140-66-9 | Xi; R38-41
N; R50-53 | Xi; N
R: 38-41-50/53
S: (2-)26-37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-50/53
10 % ≤ C < 20 %: Xi, N; R41-50/53
5 % ≤ C < 10 %: Xi, N; R36-50/53
2,5 % ≤ C < 5 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 604-076-00-1 | phenolphthalein | | 201-004-7 | 77-09-8 | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Repr. Cat. 3; R62 | T
R: 45-62-68
S: 53-45 | C ≥ 5 %: T; R45-62-68
1 % ≤ C < 5 %: T; R45-68 | |
| 604-077-00-7 | 2-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol | | 419-750-9 | 98809-58-6 | R53 | R: 53
S: 61 | | |
| 604-079-00-8 | 4,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol | | 428-970-4 | 13595-25-0 | Repr.Cat.3; R62
R43
N; R51-53 | Xn; N
R: 43-62-51/53
S: (2-)22-36/37-61 | | |
| 604-080-00-3 | 4-fluoro-3-trifluoromethylphenol | | 432-560-0 | 61721-07-1 | Xn; R20
C; R35
R43
N; R51-53 | C; N
R: 20-35-43-51/53
S: (1/2-)26-28-36/37/39-45-61 | | |
| 604-081-00-9 | 1,1-bis(4-hydroxyphenyl)-1-phenylethane | | 433-130-5 | 1571-75-1 | N; R50-53 | N
R: 50/53
S: 25-60-61 | | |
| 604-082-00-4 | 2-chloro-6-fluoro-phenol | E | 433-890-8 | 2040-90-6 | Muta.Cat.2; R46
Repr.Cat.3; R62
Xn; R22
C; R34
R43
N; R51-53 | T; N
R: 46-22-34-43-62-51/53
S: 53-45-61 | | |
| 604-083-00-X | 4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH 4 Cl), pentachlorophosphorane and phenol | | 439-270-3 | 260408-02-4 | R53 | R: 53
S: 61 | | |
| 604-084-00-5 | 1-ethoxy-2,3-difluorobenzene | | 441-000-4 | 121219-07-6 | Xn; R22
R52-53 | Xn
R: 22-52/53
S: (2-)23-61 | | |
| 604-087-00-1 | mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;
1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol | | 433-640-8 | — | F; R17
R44
R53 | F
R: 17-44-53
S: (2-)15-22-61 | | |
| 604-089-00-2 | 2-methyl-5- *tert* -butylthiophenol | | 444-970-7 | — | R10
Repr.Cat.3; R63
Xn; R48/20/22-65
Xi; R36/38
R43
R67
N; R50-53 | Xn; N
R: 10-36/38-43-48/20/22-63-65-67-50/53
S: (2-)26-36/37-62-60-61 | | |
| 605-037-00-1 | *trans* -3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;
3-[( *E* )-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde | | 421-800-1 | 120578-03-2 | R53 | R: 53
S: 22-61 | | |
| 605-038-00-7 | 3-methyl-5-phenylpentan-1-al | | 433-900-0 | 55066-49-4 | Xn; R22
Xi; R38
R43
N; R51-53 | Xn; N
R: 22-38-43-51/53
S: (2-)36/37-61 | | |
| 605-039-00-2 | 3,4-dihydroxy-5-nitrobenzaldehyde | | 441-810-8 | 116313-85-0 | Xn; R22
Xi; R41
R43 | Xn
R: 22-41-43
S: (2-)22-24-26-37/39 | | |
| 606-124-00-7 | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | | 421-080-7 | 161462-35-7 | Xn; R48/22
N; R50-53 | Xn; N
R: 48/22-50/53
S: (2-)36-60-61 | | |
| 606-125-00-2 | 1-benzylimidazolidine-2,4-dione | | 421-340-1 | 6777-05-5 | Xn; R22 | Xn
R: 22
S: (2-)22 | | |
| 606-126-00-8 | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | | 421-470-7 | 99788-75-7 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 606-128-00-9 | 2,2′-(1,3-phenylene)bis[5-chloro-1 *H* -isoindole]-1,3(2 *H* )-dione | | 422-650-8 | 148935-94-8 | R53 | R: 53
S: 61 | | |
| 606-129-00-4 | 5-amino-[2 *S* -di(methylphenyl)amino]-1,6-diphenyl-4 *Z* -hexen-3-one;
(2 *S* ,4 *Z* )-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | | 423-090-7 | 156732-13-7 | R53 | R: 53
S: 61 | | |
| 606-130-00-X | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | | 423-860-2 | 56309-94-5 | R43
R52-53 | Xi
R: 43-52/53
S: (2-)24-37-61 | | |
| 606-131-00-5 | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | E | 427-230-8 | 5571-36-8 | Repr. Cat. 2; R60
Xn; R48/22
N; R51-53 | T; N
R: 60-48/22-51/53
S: 53-45-61 | | |
| 606-132-00-0 | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | | 433-490-3 | 6563-83-3 | R43
R52-53 | Xi
R: 43-52/53
S: (2-)24-37-61 | | |
| 606-134-00-1 | androsta-1,4,9(11)-triene-3,17-dione | | 433-560-3 | 15375-21-0 | Repr. Cat.3; R62 | Xn
R: 62
S: (2-)22-36/37 | | |
| 606-135-00-7 | cyclohexadecanone | | 438-930-8 | 2550-52-9 | R53 | R: 53
S: 61 | | |
| 606-136-00-2 | (3 *S* ,6 *R* ,9 *S* ,12 *R* ,15 *S* ,18 *R* ,21 *S* ,24 *R* )-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | | 444-350-6 | 133413-70-4 | Xi; R36
R53 | Xi
R: 36-53
S: (2-)26-61 | | |
| 606-137-00-8 | *trans* -7,7′-dimethyl-(4 *H* ,4 *H′* )-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione | | 444-750-0 | 211387-26-7 | R53 | R: 53
S: 22-61 | | |
| 606-138-00-3 | (2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone | | 444-800-1 | 141645-23-0 | R10
Xn; R22-48/22
Xi; R38-41
R43
N; R50-53 | Xn; N
R: 10-22-38-41-43-48/22-50/53
S: (2-)23-26-36/37/39-60-61 | C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/53
20 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/53
10 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 606-139-00-9 | ( *S* )-4-(3,4-dichlorophenyl)-3,4-dihydro-2 *H* -naphthalen-1-one | | 444-830-5 | 124379-29-9 | R53 | R: 53
S: 61 | | |
| 606-140-00-4 | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | | 444-860-9 | 474510-57-1 | Xn; R48/22
N; R50-53 | Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61 | | |
| 606-141-00-X | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | | 418-410-7 | — | Xi; R36 | Xi
R: 36
S: (2-)26 | | |
| 606-142-00-5 | mixture of: (1 *RS* ,2 *SR* ,7 *SR* ,8 *SR,E* ) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0( 2,7 )]undecan-4-one;
(1 *RS* ,2 *SR* ,7 *SR* ,8 *SR,Z* )-10-ethylidene-3-oxatricyclo[6.2.1.0( 2,7 )]undecan-4-one;
(1 *RS* ,2 *SR* ,7 *SR* ,8 *SR,Z* )-9-ethylidene-3-oxatricyclo[6.2.1.0( 2,7 )]undecan-4-one | | 434-290-9 | — | Xn; R22
N; R51-53 | Xn; N
R: 22-51/53
S: (2-)61 | | |
| 607-580-00-X | ethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate | | 422-360-1 | 100491-29-0 | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)22-24-37-61 | | |
| 607-618-00-5 | menadione sodium bisulfite;
2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt | | 204-987-0 | 130-37-0 | Xi; R36/38
N; R50-53 | Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61 | | |
| 607-619-00-0 | menadione nicotinamide bisulfite;
1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1) | | 277-543-7 | 73581-79-0 | Xi; R36/38
N; R50-53 | Xi; N
R: 36/38-50/53
S: (2-)24/25-60-61 | | |
| 607-620-00-6 | trisodium nitrilotriacetate | | 225-768-6 | 5064-31-3 | Carc. Cat. 3; R40
Xn; R22
Xi; R36 | Xn
R: 22-36-40
S: (2-)26-36/37-46 | C ≥ 25 %: Xn; R22-36-40
20 ≤ % C < 25 %: Xn; R36-40
5 ≤ % C < 20 %: Xn; R40 | |
| 607-621-00-1 | milbemectin (ISO);
[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)] | | — | — | Xn; R20/22
N; R50-53 | Xn; N
R: 20/22-50/53
S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R20/22-50/53
0,25 % ≤ C < 25 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53 | |
| 607-622-00-7 | 2-ethylhexyl-2-ethylhexanoate | | 231-057-1 | 7425-14-1 | Repr. Cat. 3; R63 | Xn
R: 63
S: (2-)36/37 | | |
| 607-623-00-2 | diisobutyl phthalate | | 201-553-2 | 84-69-5 | Repr. Cat. 2; R61
Repr. Cat. 3; R62 | T
R: 61-62
S: 53-45 | C ≥ 25 %: T; R61-62
5 % ≤ C < 25 %: Xn; R62 | |
| 607-624-00-8 | perfluorooctane sulfonic acid;
heptadecafluorooctane-1-sulfonic acid; [1]
potassium perfluorooctanesulfonate;
potassium heptadecafluorooctane-1-sulfonate; [2]
diethanolamine perfluorooctane sulfonate; [3]
ammonium perfluorooctane sulfonate;
ammonium heptadecafluorooctanesulfonate; [4]
lithium perfluorooctane sulfonate;
lithium heptadecafluorooctanesulfonate [5] | E | 217-179-8 [1]
220-527-1 [2]
274-460-8 [3]
249-415-0 [4]
249-644-6 [5] | 1763-23-1 [1]
2795-39-3 [2]
70225-14-8 [3]
29081-56-9 [4]
29457-72-5 [5] | Carc. Cat. 3; R40
Repr. Cat. 2; R61
T; R48/25
Xn; R20/22
R64
N; R51-53 | T; N
R: 61-20/22-40-48/25-64-51/53
S: 53-45-61 | | |
| 607-625-00-3 | clodinafop-propargyl (ISO) | | — | 105512-06-9 | Xn; R22-48/22
R43
N; R50-53. | Xn; N
R: 22-43-48/22-50/53
S: (2-)24-36/37-46-60-61 | C ≥ 25 %: Xn, N; R22-43-48/22-50/53
10 % ≤ C < 25 %: Xn, N; R43-48/22-51/53
2,5 % ≤ C < 10 %: Xi, N; R43-51/53
0,25 % ≤ C < 2,5 %: Xi; R43-52/53
0,001 % ≤ C < 0,25 %: Xi; R43 | |
| 607-626-00-9 | ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1 *H* -1,2,4-triazole-3-carboxylate | | 401-290-5 | 103112-35-2 | Carc.Cat.2; R45
N; R50-53 | T; N
R: 45-50/53
S: 53-45-60-61 | | |
| 607-627-00-4 | [(4 *S* ,5 *S* )-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate | | 416-360-0 | 162221-28-5 | R43 | Xi
R: 43
S: (2-)22-24-37 | | |
| 607-628-00-X | 4-oxo-4-( *p* -tolyl)butyric acid adduct with 4-ethylmorpholine | | 419-240-6 | 171054-89-0 | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 607-629-00-5 | [[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid | | 419-270-1 | 123599-82-6 | Xi; R36 | Xi
R: 36
S: (2-)26 | | |
| 607-630-00-0 | acrylic acid, 3-(trimethoxysilyl)propyl ester | | 419-560-6 | 4369-14-6 | Xn; R20
C; R34
R43
R52-53 | C
R: 20-34-43-52/53
S: (1/2-)26-36/37/39-45-61 | | |
| 607-631-00-6 | mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;
(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate | | 442-300-8 | — | R43 | Xi
R: 43
S: (2-)24-37 | | |
| 607-632-00-1 | *N* -[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide | | 420-210-1 | 111244-14-5 | R53 | R: 53
S: 61 | | |
| 607-633-00-7 | trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[( *E* )-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate | | 440-480-2 | 341026-59-3 | Xi; R41
R43 | Xi
R: 41-43
S: (2-)22-24-26-37/39 | | |
| 607-634-00-2 | ( *S* )-(-)-2-acetoxypropionylchloride;
(1 *S* )-2-chloro-1-methyl-2-oxoethyl acetate | | 420-610-4 | 36394-75-9 | Xn; R22
C; R34
R43 | C
R: 22-34-43
S: (1/2-)23-26-36/37/39-45 | | |
| 607-635-00-8 | trisodium *N* -(3-propionato)-L-aspartate | | 422-090-4 | 172737-80-3 | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 607-636-00-3 | 1-bromo-2-methylpropyl propionate | | 422-900-6 | 158894-67-8 | R10
Carc.Cat.3; R40
C; R34
R43 | C
R: 10-34-40-43
S: (1/2-)7/9-8-23-26-36/37/39-45 | | |
| 607-637-00-9 | disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate | | 423-730-5 | 250688-43-8 | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 607-638-00-4 | 2-hydroxybenzoic acid 2-butyloctyl ester | | 431-090-3 | 190085-41-7 | R53 | R: 53
S: 61 | | |
| 607-639-00-X | 2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate | | 431-770-1 | 216698-07-6 | R53 | R: 53
S: 61 | | |
| 607-641-00-0 | 2-(formylamino)-3-thiophenecarboxylic acid;
2-formamido-3-thiophenecarboxylic acid | | 431-930-9 | 43028-69-9 | Xn; R22
R43 | Xn
R: 22-43
S: (2-)22-24-37 | | |
| 607-642-00-6 | 3,6,9-trithiaundecamethylene-1,11-dimethacrylate | | 432-210-7 | 141631-22-3 | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 607-643-00-1 | dimethyl (2 *S* )-2-hydroxysuccinate | | 432-310-0 | 617-55-0 | R10
Xi; R41
R43 | Xi
R: 10-41-43
S: (2-)24-26-37/39-43 | | |
| 607-644-00-7 | methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate | | 432-350-9 | 81752-87-6 | Xi; R38 | Xi
R: 38
S: (2-)37 | | |
| 607-645-00-2 | tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate | | 432-550-6 | 243858-01-7 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 607-646-00-8 | D-erythro-hexanoic acid 2,4-dideoxy-3,5- *O* -(1-methylethylidene)-1,1-dimethylethylester;
*tert* -butyl 2-[(4 *R* ,6 *S* )-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate | | 432-960-5 | 124655-09-0 | Xn; R22 | Xn
R: 22
S: (2-)25 | | |
| 607-647-00-3 | 5-acetoxy-2-( *R,S* )butyryloxymethyl-1,3-oxathiolane | | 433-530-1 | 143446-73-5 | Xn; R22
R43
N; R50 | Xn; N
R: 22-43-50
S: (2-)24-37-57-61 | | |
| 607-649-00-4 | [3-(chlorocarbonyl)-2-methylphenyl]acetate | | 433-690-0 | 167678-46-8 | C; R35
R43 | C
R: 35-43
S: (1/2-)7/8-26-36/37/39-45 | | |
| 607-650-00-X | 2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate | | 433-910-5 | 145153-52-2 | R43 | Xi
R: 43
S: (2-)24-37 | | |
| 607-651-00-5 | sodium 2-(nonanoyloxy)benzenesulfonate | | 434-360-9 | 91125-43-8 | Xi; R41
R43 | Xi
R: 41-43
S: (2-)24-26-37/39 | | |
| 607-652-00-0 | ethyl *N* 2 -dodecanoyl-L-argininate hydrochloride | | 434-630-6 | 60372-77-2 | Xi; R41
N; R50 | Xi; N
R: 41-50
S: (2-)26-39-61 | | |
| 607-653-00-6 | tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate | | 434-840-8 | 225786-91-4 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 607-654-00-1 | ( *S* )-3-hydroxy-γ-butyrolactone | | 434-990-4 | 7331-52-4 | R43 | Xi
R: 43
S: (2-)23-24-37 | | |
| 607-655-00-7 | ethyl 6,8-dichlorooctanoate | | 435-080-1 | 1070-64-0 | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)24-37-61 | | |
| 607-656-00-2 | sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid | | 435-350-7 | 141250-43-3 | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)22-26-39-61 | | |
| 607-657-00-8 | pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate | | 436-920-8 | 172399-10-9 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 607-658-00-3 | 3,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt | | 440-770-9 | 371921-63-0 | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)26-39-61 | | |
| 607-659-00-9 | pentasodium *N* -[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid | | 442-030-0 | 321912-47-4 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 607-660-00-4 | 2-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt | | 442-230-8 | 321679-52-1 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 607-661-00-X | 1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate | | 442-850-9 | 114772-40-6 | R43
R53 | Xi
R: 43-53
S: (2-)22-24-37-61 | | |
| 607-662-00-5 | methyl 2-(acetylamino)-3-chloropropionate | | 442-860-3 | 87333-22-0 | R43
N; R50-53 | Xi; N
R: 43-50/53
S: (2-)24-37-60-61 | | |
| 607-663-00-0 | bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate | | 442-980-6 | 127474-91-3 | R53 | R: 53
S: 61 | | |
| 607-664-00-6 | methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate | | 443-120-2 | 393509-79-0 | Xi; R41
N; R51-53 | Xi; N
R: 41-51/53
S: (2-)26-39-61 | | |
| 607-665-00-1 | *trans* -methyl-2-ethyl-but-2-enoate | | 443-150-6 | 101226-85-1 | R10 | R: 10
S: 23 | | |
| 607-666-00-7 | (2 *S* )-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2 *H* -isoindol-2-yl)-5-oxopentanoic acid | | 443-560-5 | 88784-33-2 | Xi; R36 | Xi
R: 36
S: (2-)26 | | |
| 607-667-00-2 | chloro-1-ethylcyclohexyl carbonate | | 444-950-8 | 99464-83-2 | Muta.Cat.3; R68
R43 | Xn
R: 43-68
S: (2-)23-36/37 | | |
| 607-668-00-8 | *trans* -2-isopropyl-5-carboxy-1,3-dioxane | | 445-770-2 | 42031-28-7 | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)22-26-39-61 | | |
| 607-669-00-3 | methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate | | 445-990-9 | 376588-17-9 | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 607-670-00-9 | dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;
(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate | | 448-700-9 | 500791-70-8 | Xn; R48/22
Xi; R41
R43
N; R50-53 | Xn; N
R: 41-43-48/22-50/53
S: (2-)22-26-36/37/39-60-61 | C ≥ 10 %: Xn, N; R41-43-48/22-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 607-671-00-4 | diethyl 1,4-cyclohexanedicarboxylate | | 417-310-0 | 72903-27-6 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 607-672-00-X | mixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;
1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;
x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate | | 419-000-0 | — | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)24-37-61 | | |
| 607-673-00-5 | 1-ethyl-5,6,7,8-tetrahydroquinolinium tosylate | | 419-570-0 | — | Xn; R22
R52-53 | Xn
R: 22-52/53
S: (2-)61 | | |
| 607-674-00-0 | branched C 10 -alkyl benzoates | | 421-090-1 | 131298-44-7 | Xn; R20 | Xn
R: 20
S: (2-)23 | | |
| 607-675-00-6 | mixture of: *cis* -9-octadecenedioic acid;
*cis* -9- *cis* -12-octadecadienedioic acid;
hexadecanedioic acid;
octadecanedioic acid | | 422-260-8 | — | Xi; R41
N; R50-53 | Xi; N
R: 41-50/53
S: (2-)26-39-60-61 | | |
| 607-676-00-1 | mixture of: 2-methylnonanedioic acid;
2,4-dimethyl-4-methoxycarbonylundecanedioic acid;
2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;
8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid | | 423-670-1 | — | Xi; R41
R43 | Xi
R: 41-43
S: (2-)24-26-37/39 | | |
| 607-677-00-7 | 2,5-dioxopyrrolidin-1-yl *N* -{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate | | 424-660-8 | — | Xn; R48/22
Xi; R41
R43 | Xn
R: 41-43-48/22
S: (2-)22-26-36/37/39 | | |
| 607-678-00-2 | mixture of: ethyl (2 *R* ,3 *R* )-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;
ethyl (2 *S* ,3 *S* )-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate | | 427-090-8 | — | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)23-25-36/37-61 | | |
| 607-679-00-8 | mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);
3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);
3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate) | | 431-440-5 | — | Xi; R41
N; R51-53 | Xi; N
R: 41-51/53
S: (2-)22-26-39-61 | | |
| 607-680-00-3 | *tert* -butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4 *S* ,6 *S* )-2,2-dimethyl[1,3]dioxan-4-yl)acetate | | 432-810-9 | — | R53 | R: 53
S: 61 | | |
| 607-681-00-9 | mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;
9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;
dihexadecyl 9-nonyl-10-octylnonadecandioate;
1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;
dioctadecyl 9-nonyl-10-octylnonadecandioate | | 432-910-2 | — | R53 | R: 53
S: 61 | | |
| 607-682-00-4 | complex mixture of Chinese gum rosin post reacted with acrylic acid | | 434-230-1 | 144413-22-9 | R53 | R: 53
S: 61 | | |
| 607-683-00-X | mixture of: methyl 3-((1 *E* )-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;
methyl 3-((1 *Z* )-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80) | | 435-450-0 | — | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)24-37-61 | | |
| 607-684-00-5 | alkenes, C 12-14 , hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts | | 435-660-2 | 243662-67-1 | Xi; R38
R43 | Xi
R: 38-43
S: (2-)24-37 | | |
| 607-685-00-0 | ammonium 2-cocoyloxyethanesulfonate | | 441-050-7 | — | Xi; R38-41 | Xi
R: 38-41
S: (2-)26-37/39 | | |
| 607-686-00-6 | 6,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate) | | 441-550-5 | — | E; R2
F; R11
Carc. Cat. 3; R40 | E; Xn
R: 2-11-40
S: (2-)7-22-36/37 | | |
| 607-687-00-1 | mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);
2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %) | | 442-800-6 | — | Xi; R38
N; R51-53 | Xi; N
R: 38-51/53
S: (2-)37-61 | | |
| 607-688-00-7 | ( *R* )-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride | | 444-320-2 | — | Xn; R22 | Xn
R: 22
S: (2-) | | |
| 607-689-00-2 | mixture of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including *cis* - and *trans* - isomers);
methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including *cis* - and *trans* -isomers) | | 444-920-4 | — | R52-53 | R: 52/53
S: 61 | | |
| 607-690-00-8 | dimethyl[2 *S* ,2 *S′* ]-6,6,6′6′-tetramethoxy-2,2′-[ *N,N′* -bis(trifluoracetyl)- *S,S′* -bi( *L* -homocysteinyl) diimino]dihexanoate | | 432-860-1 | 255387-46-3 | R43 | Xi
R: 43
S: (2-)24-37 | | |
| 607-691-00-3 | magnesium salts, fatty acids, C 16-18 and C 18 unsaturated, branched and linear | | 448-690-6 | — | R53 | R: 53
S: 61 | | |
| 607-692-00-9 | zinc salts, fatty acids, C 16-18 and C 18 unsaturated, branched and linear | | 446-470-4 | — | R53 | R: 53
S: 61 | | |
| 607-693-00-4 | hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate | | 443-860-6 | 302776-68-7 | R53 | R: 53
S: 61 | | |
| 607-694-00-X | ethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate | | 443-870-0 | 163520-33-0 | Xn; R22
R43
N; R50-53 | Xn; N
R: 22-43-50/53
S: (2-)22-36/37-60-61 | | |
| 608-042-00-7 | ( *S* )-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide | | 421-810-4 | 194602-27-2 | Xn; R22
Xi; R41
R43
N; R51-53 | Xn; N
R: 22-41-43-51/53
S: (2-)24-26-37/39-61 | | |
| 608-059-00-X | 5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1 *H* -pyrazole-3-carbonitrile | | 421-240-6 | 120068-79-3 | N; R51-53 | N
R: 51/53
S: 22-61 | | |
| 608-060-00-5 | 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile | | 421-300-1 | 138564-59-7 | N; R50-53 | N
R: 50/53
S: 22-60-61 | | |
| 608-062-00-6 | 2-fluoro-4-hydroxybenzonitrile | | 422-810-7 | 82380-18-5 | Xn; R22
Xi; R41
N; R51-53 | Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61 | | |
| 608-063-00-1 | ( *S* )-α-hydroxy-3-phenoxy-benzeneacetonitrile | | 441-070-6 | 61826-76-4 | T; R25
Xi; R41
R43
N; R50-53 | T; N
R: 25-41-43-50/53
S: (1/2-)9-26-36/37/39-45-60-61 | | |
| 608-064-00-7 | cyanomethyltrimethylammoniummethylsulfate | | 433-720-2 | — | R52-53 | R: 52/53
S: 61 | | |
| 609-069-00-7 | musk ketone;
3,5-dinitro-2,6-dimethyl-4- *tert* -butylacetophenone;
4′- *tert* -butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone | | 201-328-9 | 81-14-1 | Carc. Cat. 3; R40
N; R50-53 | Xn; N
R: 40-50/53
S: (2-)36/37-46-60-61 | | |
| 611-154-00-9 | trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate | | 403-670-6 | 92408-46-3 | R52-53 | R: 52/53
S: 61 | | |
| 611-155-00-4 | 4,4′-oxybis(benzenesulfonylazide) | | 431-850-4 | 7456-68-0 | E; R3
F; R11
Xn; R48/22
N; R50-53 | E; Xn; N
R: 3-11-48/22-50/53
S: (2-)14-22-33-35-36-60-61 | | |
| 611-156-00-X | triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate | | 432-270-4 | 221354-37-6 | Repr. Cat. 3; R62
Xn; R48/22
N; R51-53 | Xn; N
R: 48/22-62-51/53
S: (2-)36/37-61 | | |
| 611-157-00-5 | benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;
potassium sodium 3-[( *E* )-(6-{3,4-dihydroxy-2-[( *Z* )-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate | | 432-590-4 | 243869-48-9 | Xi; R36
R52-53 | Xi
R: 36-52/53
S: (2-)26-61 | | |
| 611-158-00-0 | reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride | | 421-520-8 | — | F; R11
R53 | F
R: 11-53
S: (2-)3-12-16-33-61 | | |
| 611-159-00-6 | disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate | | 421-880-6 | — | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)26-39-61 | | |
| 611-160-00-1 | mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;
1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;
reaction product of 1,1,1-tris( *p* -hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);
reaction product of 1,1,1-tris( *p* -hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2) | | 422-760-6 | — | F; R11
R53 | F
R: 11-53
S: (2-)3-12-33-61 | | |
| 611-161-00-7 | trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato- *O,O,N* ][( *Z* )-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato- *O,O,N* ]chromate(III) | | 423-100-1 | — | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 611-162-00-2 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate) | | 429-600-4 | — | Xn; R22
Xi; R41
N; R51-53 | Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61 | | |
| 611-163-00-8 | 2,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate | | 429-610-9 | — | Xn; R22
Xi; R41
N; R51-53 | Xn; N
R: 22-41-51/53
S: (2-)22-26-39-61 | | |
| 611-164-00-3 | mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;
2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);
2,2′-dimethyl-2,2′-azoheptanenitrile;
2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);
2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile) | | 429-710-2 | — | R10
R32
R44
Xn; R22
N; R51-53 | Xn; N
R: 10-22-32-44-51/53
S: (2-)12-15-16-47-51-61 | | |
| 611-165-00-9 | mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;
tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate | | 431-830-5 | — | R52-53 | R: 52/53
S: 61 | | |
| 611-166-00-4 | mixture of: pentasodium 4-amino-5-hydroxy-3-{( *E* )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{( *E* )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{( *E* )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[( *E* )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-{( *E* )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[( *E* )-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | | 432-100-9 | — | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)26-39-61 | | |
| 611-167-00-X | sodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II) | | 435-240-9 | — | R52-53 | R: 52/53
S: 61 | | |
| 611-168-00-5 | mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;
3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid | | 435-440-6 | — | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 611-169-00-0 | sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate | | 435-800-2 | — | R52-53 | R: 52/53
S: 61 | | |
| 611-170-00-6 | mixture of: trisodium 2-((1-(2-hydroxy-κ- *O* -5-(2-sulfonatoethansulfonyl)phenylazo-κ- *N* 2 )-1-phenylmethyl)azo-κ- *N* 1 )-4-sulfonatobenzoate(5-)-κ- *O* )cuprate(II);
disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ- *O* -phenylazo-κ- *N* 2 )-1-phenylmethyl)azo-κ- *N* 1 )-4-sulfonatobenzoate-κ- *O* -(5-))cuprate(II) | | 435-880-9 | — | R52-53 | R: 52/53
S: 22-61 | | |
| 611-171-00-1 | mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;
trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate | | 436-890-6 | — | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)22-26-39-61 | | |
| 611-172-00-7 | mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;
diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate | | 438-310-7 | — | E; R2
Repr. Cat. 3; R62
Xn; R22-48/22
R52-53 | E; Xn
R: 2-22-48/22-62-52/53
S: (2-)22-35-36/37-61 | | |
| 611-173-00-2 | mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;
3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt | | 440-510-4 | — | Xi; R41
R43 | Xi
R: 41-43
S: (2-)22-26-36/37/39 | | |
| 611-174-00-8 | mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;
3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt | | 442-290-5 | 457624-86-1 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 611-175-00-3 | mixture of: trisodium 5-{4-chloro-6-[ *N* -ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 5-{4-chloro-6-[ *N* -ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
disodium 5-{4-chloro-6-[ *N* -ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 5-{4-chloro-6-[ *N* -ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate | | 444-050-5 | — | Xi; R41
R52-53 | Xi
R: 41-52/53
S: (2-)22-26-39-61 | | |
| 611-176-00-9 | 2,6-bis(2,3,4-trihydroxybenzyl)- *p* -cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate | | 444-250-2 | — | E; R2
F; R11
N; R51-53 | E; N
R: 2-11-51/53
S: (2-)22-61 | | |
| 611-177-00-4 | mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);
trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III) | | 444-290-0 | 508202-43-5 | Xi; R41
R43
R52-53 | Xi
R: 41-43-52/53
S: (2-)22-24-26-37/39-61 | | |
| 611-178-00-X | mixture of: pentasodium 4-amino-5-hydroxy-3-{( *E* )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{( *E* )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-3-{( *E* )-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[( *E* )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
tetrasodium 4-amino-5-hydroxy-6-[( *E* )-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[( *E* )-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[( *E* )-4-(vinylsulfonyl)phenylazo]-6-[( *E* )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[( *E* )-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;
trisodium 4-amino-5-hydroxy-3-[( *E* )-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate | | 445-280-9 | — | Xi; R41
R43
R52-53 | Xi
R: 41-43-52/53
S: (2-)24-26-37/39-61 | | |
| 611-179-00-5 | mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;
2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate | | 450-010-8 | — | Xi; R41
R43 | Xi
R: 41-43
S: (2-)22-24-26-37/39 | | |
| 611-180-00-0 | iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts | | 417-850-7 | — | N; R51-53 | N
R: 51/53
S: 22-61 | | |
| 612-238-00-8 | (3-chloro-2-hydroxypropyl) trimethylammonium chloride … % | B | 222-048-3 | 3327-22-8 | Carc. Cat. 3, R40
R52-53 | Xn
R: 40-52/53
S: 36/37-61 | | |
| 612-239-00-3 | biphenyl-3,3′,4,4′-tetrayltetraamine;
diaminobenzidine | | 202-110-6 | 91-95-2 | Carc. Cat. 2; R45
Muta. Cat. 3; R68 | T
R: 45-68
S: 53-45 | | |
| 612-240-00-9 | pyrimethanil (ISO);
*N* -(4,6-dimethylpyrimidin-2-yl)aniline | | — | 53112-28-0 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 612-241-00-4 | piperazine hydrochloride; [1]
piperazine dihydrochloride; [2]
piperazine phosphate [3] | | 228-042-7 [1]
205-551-2 [2]
217-775-8 [3] | 6094-40-2 [1]
142-64-3 [2]
1951-97-9 [3] | Repr. Cat. 3; R62-63
Xi; R36/38
R42/43
R52-53 | Xn
R: 36/38-42/43-62-63-52/53
S: (1/2-)22-36/37-45-63-61 | | |
| 612-242-00-X | cyprodinil (ISO);
4-cyclopropyl-6-methyl- *N* -phenylpyrimidin-2-amine | | — | 121552-61-2 | R43
N; R50-53 | Xi; N
R: 43-50/53
S: (2-)24-37-46-60-61 | C ≥ 2,5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-243-00-5 | (1 *S-cis* )-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- *N* -methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate | | 420-560-3 | 79617-97-3 | Xi; R41
N; R50-53 | Xi; N
R: 41-50/53
S: (2-)26-39-60-61 | C ≥ 10 %: Xi, N; R41-50/53
5 % ≤ C < 10 %: Xi, N; R36-50/53
2,5 % ≤ C < 5 %: N; R50/53
0,25 % ≤ C < 2, 5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-244-00-0 | 3-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride | | 421-310-6 | 87691-88-1 | Repr. Cat. 3; R62
Xn; R22
Xi; R36
R43
N; R50-53 | Xn; N
R: 22-36-43-62-50/53
S: (2-)22-26-36/37/39-60-61 | | |
| 612-245-00-6 | 2-ethylphenylhydrazine hydrochloride | | 421-460-2 | 19398-06-2 | Carc. Cat. 3; R40
T; R48/25
Xn; R22
Xi; R41
R43
N; R50-53 | T; N
R: 22-40-41-43-48/25-50/53
S: (1/2-)22-26-36/37/39-45-60-61 | C ≥ 25 %: T, N; R22-40-41-43-48/25-50/53
10 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/53
5 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/53
2,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-246-00-1 | (2-chloroethyl)(3-hydroxypropyl)ammonium chloride | E | 429-740-6 | 40722-80-3 | Carc. Cat. 2; R45
Muta. Cat. 2; R46
Xn; R48/22
R43
R52-53 | T
R: 45-46-43-48/22-52/53
S: 53-45-61 | | |
| 612-247-00-7 | *N* -[3-(1,1-dimethylethyl)-1 *H* -pyrazol-5-yl]- *N′* -hydroxy-4-nitrobenzenecarboximidamide | | 423-530-8 | 152828-23-4 | T; R48/25
Xn; R22
R52-53 | T
R: 22-48/25-52/53
S: (1/2-)22-36-45-61 | | |
| 612-248-00-2 | reaction product of diphenylamine, phenothiazine, and alkenes, branched (C 8-10 , C 9 -rich) | | 439-540-0 | — | Xi; R38
R43
R53 | Xi
R: 38-43-53
S: (2-)24-37-61 | | |
| 612-249-00-8 | 4-[(3-chlorophenyl)(1 *H* -imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride | | 425-030-5 | 159939-85-2 | Repr. Cat. 3; R62
Xn; R22
C; R34
R43
N; R51-53 | C; N
R: 22-34-43-62-51/53
S: (1/2-)22-26-36/37/39-45-61 | | |
| 612-250-00-3 | chloro- *N,N* -dimethylformiminium chloride | E | 425-970-6 | 3724-43-4 | R14
Repr. Cat. 2; R61
Xn; R22
C; R35 | T; C
R: 61-14-22-35
S: 53-45 | | |
| 612-251-00-9 | *cis* -1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride | | 426-020-3 | 51229-78-8 | F; R11
Repr. Cat. 3; R63
Xn; R22
Xi; R38
R43
N; R51-53 | F; Xn; N
R: 11-22-38-43-63-51/53
S: (2-)7-22-33-36/37-61 | | |
| 612-252-00-4 | imidacloprid (ISO);
1-(6-chloropyridin-3-ylmethyl)- *N* -nitroimidazolidin-2-ylidenamine | | 428-040-8 | 138261-41-3 | Xn; R22
N; R50-53 | Xn; N
R: 22-50/53
S: (2-)22-57-60-61 | | |
| 612-253-00-X | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3 *H* -quinazolin-4-one;
[containing < 0,5 % formamide (EC No 200-842-0)] | | 429-400-7 | 199327-61-2 | R52-53 | R: R52/53
S: 61 | | |
| 612-253-01-7 | 7-methoxy-6-(3-morpholin-4-yl-propoxy)-3 *H* -quinazolin-4-one;
[containing ≥ 0,5 % formamide (EC No 200-842-0)] | | 429-400-7 | 199327-61-2 | Repr. Cat. 2; R61
R52-53 | T
R: 61-52/53
S: 53-45-61 | | |
| 612-254-00-5 | reaction products of diisopropanolamine with formaldehyde (1:4) | | 432-440-8 | 220444-73-5 | Carc. Cat. 3; R40
Xn; R22
C; R34
R43
N; R51-53 | C; N
R: 22-34-40-43-51/53
S: (1/2-)13-25-26-36/37/39-45-61 | | |
| 612-255-00-0 | 1-(3-methoxypropyl)-4-piperidinamine | | 431-950-8 | 179474-79-4 | Xn; R21/22
C; R34
R52-53 | C
R: 21/22-34-52/53
S: (1/2-)26-36/37/39-45-61 | | |
| 612-256-00-6 | benzyl( *S* )-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate | | 427-470-3 | 137864-22-3 | Xn; R22
R43 | Xn
R: 22-43
S: (2-)36/37 | | |
| 612-257-00-1 | tripropylammonium dihydrogenphosphate | | 433-700-3 | 35687-90-2 | Xn; R22 | Xn
R: 22
S: (2-)22 | | |
| 612-259-00-2 | *N* -ethyl-3-trimethoxysilyl-2-methyl-propanamine | | 437-720-3 | 227085-51-0 | Xi; R41 | Xi
R: 41
S: (2-)26-39 | | |
| 612-261-00-3 | 3,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline | | 441-190-9 | 121451-05-6 | Xn; R22
R43
N; R50-53 | Xn; N
R: 22-43-50/53
S: (2-)24-37-60-61 | C ≥ 25 %: Xn, N; R22-43-50/53
2,5 % ≤ C < 25 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-265-00-5 | bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate | | 444-360-0 | 191617-13-7 | R52-53 | R: 52/53
S: 61 | | |
| 612-266-00-0 | 3-chloro-4-(3-fluorobenzyloxy)aniline | | 445-590-4 | 202197-26-0 | Muta. Cat. 3; R68
Xn; R22-48/22
N; R50-53 | Xn; N
R: 22-48/22-68-50/53
S: (2-)22-36/37-60-61 | | |
| 612-267-00-6 | bis(hydrogenated tallow C 16-18 -alkyl)hydroxylamine | | 418-370-0 | — | R43
R53 | Xi
R: 43-53
S: (2-)36/37-61 | | |
| 612-269-00-7 | mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1 *H* -benzotriazole;
1-[di(4-octylphenyl)aminomethyl]-4-methyl-1 *H* -benzotriazole;
mixture of: *N* -[(5-methyl-1 *H* -benzotriazol-1-yl)methyl]-4-octyl- *N* -(4-octylphenyl)aniline;
*N* -[(4-methyl-1 *H* -benzotriazol-1-yl)methyl]-4-octyl- *N* -(4-octylphenyl)aniline | | 420-720-2 | — | R53 | R: 53
S: 22-61 | | |
| 612-270-00-2 | ( *S* )-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride | | 433-010-2 | — | Xn; R22
R43
R52-53 | Xn
R: 22-43-52/53
S: (2-)22-36/37-61 | | |
| 612-271-00-8 | mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;
ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate | | 434-970-5 | 160987-57-5 | R53 | R: 53
S: 61 | | |
| 612-272-00-3 | ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate | | 435-210-5 | — | N; R51-53 | N
R: 51/53
S: 61 | | |
| 612-273-00-9 | alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride | | 435-650-8 | — | Xn; R22
C; R35
N; R50-53 | C; N
R: 22-35-50/53
S: (1/2-)26-36/37/39-45-60-61 | | |
| 612-274-00-4 | ( *R,S* )-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate | | 445-750-3 | — | Xn; R22
Xi; R41
R43
R52-53 | Xn
R: 22-41-43-52/53
S: (2-)22-24-26-37/39-61 | | |
| 612-275-00-X | fatty acids, C 18 -unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil | | 447-880-6 | 206565-89-1 | Xi; R38-41
R43
N; R50-53 | Xi; N
R: 38-41-43-50/53
S: (2-)23-26-36/37/39-60-61 | C ≥ 20 %: Xi, N; R38-41-43-50/53
10 % ≤ C < 20 %: Xi, N; R41-43-50/53
5 % ≤ C < 10 %: Xi, N; R36-43-50/53
2,5 % ≤ C < 5 %: Xi, N; R43-50/53
1 % ≤ C < 2,5 %: Xi, N; R43-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 612-276-00-5 | 1-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts | | 451-430-4 | 500717-36-2 | Xi; R41
R43
R52-53 | Xi
R: 41-43-52/53
S: (2-)22-24-26-36/37/39-61 | | |
| 612-277-00-0 | mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;
4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium | | 451-440-9 | 586372-44-3 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 612-278-00-6 | ethidium bromide;
3,8-diamino-1-ethyl-6-phenylphenantridinium bromide | | 214-984-6 | 1239-45-8 | Muta. Cat. 3; R68
T+; R26
Xn; R22 | T+
R: 22-26-68
S: (1/2-)28-36/37-45-63 | | |
| 612-279-00-1 | ( *R,S* )-2-amino-3,3-dimethylbutane amide | | 447-860-7 | 144177-62-8 | Repr. Cat. 3; R62
Xn; R48/22
Xi; R36/38
R43 | Xn
R: 36/38-43-48/22-62
S: (2-)22-26-36/37 | | |
| 612-280-00-7 | 3-amino-9-ethyl carbazole;
9-ethylcarbazol-3-ylamine | H | 205-057-7 | 132-32-1 | Carc. Cat. 2; R45 | T
R: 45
S: 53-45 | | |
| 613-116-01-4 | tolylfluanid (ISO);
dichloro- *N* -[(dimethylamino)sulphonyl]fluoro- *N* -( *p* -tolyl)methanesulphenamide;
[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm] | | 211-986-9 | 731-27-1 | Xi; R36/37/38
R43
N; R50 | Xi; N
R: 36/37/38-43-50
S: (2-)25-36/37-46-61 | C ≥ 20 %: Xi, N; R36/37/38-43-50
2,5 % ≤ C < 20 %: Xi, N; R43-50
1 % ≤ C < 2,5 %: Xi; R43 | |
| 613-280-00-X | tetrahydro-1,3-dimethyl-1 *H* -pyrimidin-2-one;
dimethyl propyleneurea | | 230-625-6 | 7226-23-5 | Repr. Cat. 3; R62
Xn; R22
Xi; R41 | Xn
R: 22-41-62
S: 26-36/37/39 | | |
| 613-281-00-5 | quinoline | E | 202-051-6 | 91-22-5 | Carc. Cat. 2; R45
Muta. Cat. 3; R68
Xn; R21/22
Xi; R36/38
N; R51-53 | T; N
R: 45-21/22-36/38-68-51/53
S: 53-45-61 | | |
| 613-282-00-0 | triticonazole (ISO);
( *RS* )-( *E* )-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1 *H* -1,2,4-triazol-1-methyl)cyclopentanol | | — | 131983-72-7 | N; R51-53 | N
R: 51/53
S: 61 | | |
| 613-283-00-6 | ketoconazole;
1-[4-[4-[[(2 *SR* ,4 *RS* )-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone | E | 265-667-4 | 65277-42-1 | Repr. Cat. 2; R60
T; R25
Xn; R48/22
N; R50-53 | T; N
R: 60-25-48/22-50/53
S: 53-45-60-61 | | |
| 613-284-00-1 | metconazole (ISO);
(1 *RS* ,5 *RS* ;1 *RS* ,5 *SR* )-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1 *H* -1,2,4-triazol-1-ylmethyl)cyclopentanol | | — | 125116-23-6 | Repr. Cat. 3; R63
Xn; R22
N; R51-53 | Xn; N
R: 22-63-51/53
S: (2-)36/37-46-61 | | |
| 613-285-00-7 | 1-hydroxybenzotriazole, anhydrous; [1]
1-hydroxybenzotriazole, monohydrated [2] | | 219-989-7 [1]
219-989-7 [2] | 2592-95-2 [1]
123333-53-9 [2] | E; R2 | E
R: 2
S: 16-35 | | |
| 613-286-00-2 | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | | 418-260-2 | 183196-57-8 | R43 | Xi
R: 43
S: (2-)24-37 | | |
| 613-286-01-X | potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;
[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)] | | 418-260-2 | 183196-57-8 | Repr. Cat. 2; R61
R43 | T
R: 61-43
S: 53-45 | | |
| 613-287-00-8 | 1-(3-iodo-4-aminobenzyl)-1 *H* -1,2,4-triazole | | 419-540-7 | 160194-26-3 | Xn; R22
R43
N; R51-53 | Xn; N
R: 22-43-51/53
S: (2-)24-37-61 | | |
| 613-288-00-3 | 1,3-bis(dimethylcarbamoyl)-imidazolium chloride | | 420-930-4 | 135756-61-5 | Xn; R22
Xi; R41
R52-53 | Xn
R: 22-41-52/53
S: (2-)22-26-37/39-61 | | |
| 613-289-00-9 | 3-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1 *H* -pyrazole | | 432-020-4 | 142623-48-1 | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 613-290-00-4 | 4-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3 *H* )-one hydrochloride | | 432-470-1 | 189012-93-9 | Xi; R41
R43
N; R50-53 | Xi; N
R: 41-43-50/53
S: (2-)24-26-37/39-60-61 | | |
| 613-291-00-X | 2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3 *H* -1,2,4-triazol-3-one | | 434-820-9 | 106461-41-0 | Xn; R48/22
N; R50-53 | Xn; N
R: 48/22-50/53
S: (2-)22-36-60-61 | | |
| 613-292-00-5 | *N,N′,N″* -tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine | | 435-010-8 | 26157-73-3 | Muta. Cat. 3; R68
R52-53 | Xn
R: 68-52/53
S: (2-)36/37-61 | | |
| 613-293-00-0 | 2-(4- *tert* -butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1 *H* -pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di- *tert* -butyl-4-methylcyclohexylester | | 448-050-6 | 444065-11-6 | R53 | R: 53
S: 61 | | |
| 613-294-00-6 | 2-hexyldecanoic acid [4-(6- *tert* -butyl-7-chloro-1 *H* -pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester | | 448-260-8 | 379268-96-9 | R53 | R: 53
S: 61 | | |
| 613-295-00-1 | 11-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride | | 448-720-8 | 363138-44-7 | Xn; R22
Xi; R41
R52-53 | Xn
R: 22-41-52/53
S: (2-)22-26-39-61 | | |
| 613-296-00-7 | pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate | | 418-270-7 | — | R43
R52-53 | Xi
R: 43-52/53
S: (2-)24-37-47-61 | | |
| 613-297-00-2 | 5-(2-bromophenyl)-2- *tert* -butyl-2 *H* -tetrazole | | 420-820-6 | — | R10
Xn; R22
N; R51-53 | Xn; N
R: 10-22-51/53
S: (2-)16-61 | | |
| 613-298-00-8 | bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1 *H* -pyridin-2-one)ethylene dilactate | | 421-560-6 | — | Xn; R48/22
Xi; R41
N; R51-53 | Xn; N
R: 41-48/22-51/53
S: (2-)22-26-36/39-61 | | |
| 613-299-00-3 | main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;
main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt | | 422-610-1 | — | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 613-300-00-7 | 1-imidazol-1-yl-octadecan-2-ol | | 434-120-3 | — | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 613-301-00-2 | dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate | | 443-910-7 | — | R53 | R: 53
S: 61 | | |
| 613-302-00-8 | disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate | | 432-980-4 | 243858-60-8 | Xi; R41 | Xi
R: 41
S: (2-)22-26-39 | | |
| 613-303-00-3 | 2-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine | | 429-800-1 | 95737-68-1 | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 613-304-00-9 | 5,6-dihydroxy-2,3-dihydro-1 *H* -indolium bromide | | 421-170-6 | 138937-28-7 | Xn; R22
Xi; R41 | Xn
R: 22-41
S: (2-)22-26-39 | | |
| 613-305-00-4 | 2-(2-hydroxy-4-octyloxyphenyl)-2 *H* -benzotriazole | | 448-630-9 | 3147-77-1 | R53 | R: 53
S: 61 | | |
| 613-306-00-X | (2,5-dioxopyrrolidin-1-yl)-9 *H* -fluoren-9-ylmethyl carbonate | | 433-520-5 | 82911-69-1 | Xn; R22
R43
N; R51-53 | Xn; N
R: 22-43-51/53
S: (2-)24-37-61 | | |
| 613-307-00-5 | clothianidin (ISO);
3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine | | — | 210880-92-5 | Xn; R22
N; R50-53 | Xn; N
R: 22-50/53
S: (2-)46-60-61 | C ≥ 25 %: Xn, N; R22-50/53
2,5 % ≤ C < 25 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 613-308-00-0 | 2-amino-5-methylthiazole | | 423-800-5 | 7305-71-7 | Xn; R22-48/22
N; R50-53 | Xn; N
R: 22-48/22-50/53
S: (2-)22-36-60-61 | | |
| 613-309-00-6 | 1-methyl-3-phenyl-1-piperazine | | 431-180-2 | 5271-27-2 | Xn; R21/22
Xi; R38-41
R52-53 | Xn
R: 21/22-38-41-52/53
S: (2-)26-36/37/39-61 | | |
| 613-310-00-1 | (-)(3 *S* ,4 *R* )-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)- *N* -benzylpiperidine hydrochloride | | 432-360-3 | 105813-13-6 | Xn; R22
R43
N; R50-53 | Xn; N
R: 22-43-50/53
S: (2-)22-24-37-60-61 | | |
| 613-311-00-7 | methyl-5-nitrophenyl-guanidine | | 435-500-1 | 152460-07-6 | Xn; R22
Xi; R36
R43
R52-53 | Xn
R: 22-36-43-52/53
S: (2-)22-24-26-37-61 | | |
| 613-312-00-2 | 2-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride | | 420-200-5 | — | Xn; R22
Xi; R41
R43
R52-53 | Xn
R: 22-41-43-52/53
S: (2-)22-26-36/37/39-61 | | |
| 613-313-00-8 | 2-(4-(4-(3-pyridinyl)-1 *H* -imidazol-1-yl)butyl)-1 *H* -isoindole-1,3(2 *H* )-dione | | 442-780-9 | 173838-67-0 | R52-53 | R: 52/53
S: 61 | | |
| 613-314-00-3 | 4-decyloxazolidin-2-one;
4-decyl-1,3-oxazolidin-2-one | | 443-770-7 | 7693-82-5 | N; R50-53 | N
R: 50/53
S: 22-24-60-61 | | |
| 613-315-00-9 | tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate | | 430-390-1 | — | Xn; R20
R52-53 | Xn
R: 20-52/53
S: (2-)25-61 | | |
| 613-316-00-4 | trimethylopropane tri(3-aziridinylpropanoate);
(TAZ) | H | 257-765-0 | 52234-82-9 | Muta. Cat. 3; R68
Xi; R41
R43 | Xn
R: 41-43-68
S: 26-36/37/39-42 | | |
| 615-044-00-1 | 4-chlorophenylisocyanate | | 203-176-9 | 104-12-1 | T+; R26
Xn; R22
Xi; R37/38-41
R42
N; R50-53 | T+; N
R: 22-26-37/38-41-42-50/53
S: (1/2-)26-28-36/37/39-45-63-60-61 | | |
| 615-045-00-7 | 4,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate) | | 420-530-1 | — | R42/43
R53 | Xn
R: 42/43-53
S: (2-)23-24-37-45-61 | | |
| 616-126-00-X | 1-methyl-4-nitro-3-propyl-1 *H* -pyrazole-5-carboxamide | | 423-960-6 | 139756-01-7 | Xn; R22-48/22
R52-53 | Xn
R: 22-48/22-52/53
S: (2-)22-36/37-61 | | |
| 616-164-00-7 | dimoxystrobin (ISO);
( *E* )-2-(methoxyimino)- *N* -methyl-2-[α-(2,5-xylyloxy)- *o* -tolyl]acetamide | | — | 149961-52-4 | Carc. Cat. 3; R40
Repr. Cat. 3; R63
Xn; R20
N; R50-53 | Xn; N
R: 20-40-63-50/53
S: (2-)36/37-46-60-61 | C ≥ 25 %: Xn, N; R20-40-63-50/53
5 % ≤ C < 25 %: Xn, N; R40-63-50/53
2,5 % ≤ C < 5 %: Xn, N; R40-50/53
1 % ≤ C < 2,5 %: Xn, N; R40-51/53
0,25 % ≤ C < 1 %: N; R51/53
0,025 % ≤ C < 0,25 %: R52-53 | |
| 616-165-00-2 | beflubutamid (ISO);
( *RS* )- *N* -benzyl-2-(α,α,α,4-tetrafluoro- *m* -tolyoxy)butyramide | | — | 113614-08-7 | N; R50-53 | N
R: 50/53
S: 60-61 | C ≥ 0,25 %: N; R50/53
0,025 % ≤ C < 0,25 %: N; R51/53
0,0025 % ≤ C < 0,025 %: R52/53 | |
| 616-166-00-8 | cyazofamid (ISO);
4-chloro-2-cyano- *N,N* -dimethyl-5- *p* -tolylimidazole-1-sulfonamide | | — | 120116-88-3 | N; R50-53 | N
R: 50/53
S: 60-61 | C ≥ 2,5 %: N; R50/53
0,25 % ≤ C < 2,5 %: N; R51-53
0,025 % ≤ C < 0,25 %: R52/53 | |
| 616-167-00-3 | *N,N* -dibutyl-(2,5-dihydro-5-thioxo-1 *H* -tetrazol-1-yl)acetamide | | 418-290-6 | 168612-06-4 | Xi; R36
R43 | Xi
R: 36-43
S: (2-)24-26-37 | | |
| 616-168-00-9 | 1-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium | | 418-440-0 | 136997-71-2 | R43 | Xi
R: 43
S: (2-)22-24-37 | | |
| 616-169-00-4 | 4-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one | | 420-220-4 | 92771-56-7 | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 616-170-00-X | (2 *R* )-2-amino-2-phenylacetamide | | 420-370-0 | 6485-67-2 | Xi; R36
R43 | Xi
R: 36-43
S: (2-)22-26-36/37 | | |
| 616-171-00-5 | 2-(para-chlorophenyl)glycineamide | | 420-830-0 | 102333-75-5 | Xi; R41
R43 | Xi
R: 41-43
S: (2-)24-26-37/39 | | |
| 616-172-00-0 | *N* -(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;
(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl | | 423-840-3 | 14691-89-5 | Xn; R22 | Xn
R: 22
S: (2-)22 | | |
| 616-174-00-1 | 2-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride | | 424-560-4 | 151257-01-1 | Xn; R22
Xi; R36 | Xn
R: 22-36
S: (2-)22-26 | | |
| 616-175-00-7 | 2-(2-hexyldecyloxy)benzamide | | 431-230-3 | 202483-62-3 | R53 | R: 53
S: 61 | | |
| 616-176-00-2 | 3- *N,N* -bis(methoxyethyl)aminoacetanilide | | 432-530-7 | 24294-01-7 | Xn; R22
R52-53 | Xn
R: 22-52/53
S: (2-)22-24-61 | | |
| 616-177-00-8 | (3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1 *H* -pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;
*N* -[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1 *H* -pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide | | 432-970-1 | 217324-98-6 | R53 | R: 53
S: 61 | | |
| 616-178-00-3 | *N* -(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide | | 434-500-9 | 52583-35-4 | R53 | R: 53
S: 22-61 | | |
| 616-179-00-9 | 2-chloro- *N* -(4-methylphenyl)acetamide | | 435-170-9 | 16634-82-5 | Xi; R41
R43
N; R50-53 | Xi; N
R: 41-43-50/53
S: (2-)22-26-36/37/39-60-61 | | |
| 616-180-00-4 | *N,N* -(dimethylamino)thioacetamide hydrochloride | | 435-470-1 | 27366-72-9 | Repr. Cat. 2; R61
N; R50-53 | T; N
R: 61-50/53
S: 53-45-60-61 | | |
| 616-181-00-X | 4′-methyldodecane-1-sulfonanilide | | 435-490-9 | 17417-32-2 | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 616-182-00-5 | *N′* -(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide | | 435-860-1 | 214417-91-1 | R43
N; R51-53 | Xi; N
R: 43-51/53
S: (2-)24-37-61 | | |
| 616-183-00-0 | *N* -dodecyl-4-methoxybenzamide | | 442-340-6 | 1854-15-5 | R53 | R: 53
S: 61 | | |
| 616-184-00-6 | 3-methyl- *N* -(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide | | 442-560-2 | 105043-55-8 | R53 | R: 53
S: 61 | | |
| 616-186-00-7 | *N,N′* -(2-chloro-1,4-phenylene)bis(3-oxobutaneamide) | | 443-010-4 | 53641-10-4 | R52-53 | R: 52/53
S: 61 | | |
| 616-188-00-8 | 2-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo- *N* -(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide | | 443-980-9 | 221215-20-9 | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 616-189-00-3 | *N* -[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1 *H* -isoindol-5-ylazo)-phenyl]acetamide | | 444-780-4 | 452962-97-9 | R53 | R: 53
S: 61 | | |
| 616-190-00-9 | *N* -decyl-4-nitrobenzamide | | 445-880-0 | 64026-19-3 | R53 | R: 53
S: 61 | | |
| 616-191-00-4 | 2-ethyl- *N* -methyl- *N* -(3-methylphenyl)butanamide | | 446-190-2 | 406488-30-0 | Xn; R22
Xi; R36/38
R43
N; R51-53 | Xn; N
R: 22-36/38-43-51/53
S: (2-)24-26-37-61 | | |
| 616-192-00-X | 2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′- *tert* -butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide | | 448-060-0 | 727678-39-9 | R53 | R: 53
S: 61 | | |
| 616-193-00-5 | *N* -[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1 *H* -isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide | | 449-940-7 | 368450-39-9 | R53 | R: 53
S: 61 | | |
| 616-194-00-0 | 2,2-diethoxy- *N,N* -dimethylacetamide | | 449-950-1 | 34640-92-1 | Xi; R36 | Xi
R: 36
S: (2-)26 | | |
| 616-196-00-1 | disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)- *N* -dodecyl-2-naphthamide | | 419-990-4 | — | N; R50-53 | N
R: 50/53
S: 60-61 | | |
| 616-197-00-7 | mixture of: potassium *N* -[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;
*N* -[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide | | 422-500-1 | — | Xn; R48/22 | Xn
R: 48/22
S: (2-)22-36 | | |
| 616-198-00-2 | 1,3-bis[12-hydroxy-octadecamide- *N* -methylene]-benzene | | 423-300-7 | — | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 616-200-00-1 | mixture of: *N,N′* -ethane-1,2-diylbis(hexanamide);
12-hydroxy- *N* -[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;
*N,N′* -ethane-1,2-diylbis(12-hydroxyoctadecanamide) | | 432-430-3 | — | R43
R53 | Xi
R: 43-53
S: (2-)24-37-61 | | |
| 616-201-00-7 | 12-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine | | 432-840-2 | 220926-97-6 | Xn; R20
R53 | Xn
R: 20-53
S: (2-)22-61 | | |
| 616-202-00-2 | mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[ *N* -(2,4-dimethylphenyl)]-3-oxo-butanamide;
2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]- *N* -(2-methylphenyl)-3-oxo-butanamide;
2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]- *N* -(2-carboxylphenyl)-3-oxo-butanamide | | 434-330-5 | — | Carc. Cat. 3; R40
R43
R53 | Xn
R: 40-43-53
S: (2-)36/37-61 | | |
| 616-203-00-8 | mixture of: *N* -[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1 *H* -isoindol-5-yl-azo)phenyl]acetamide;
*N* -[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1 *H* -isoindol-5-ylazo)5-diethylaminophenyl]acetamide | | 442-280-0 | — | R53 | R: 53
S: 61 | | |
| 616-204-00-3 | *N,N″* -(methylenedi-4,1-phenylene)bis[ *N′* -octylurea] | | 451-060-3 | 122886-55-9 | R53 | R: 53
S: 61 | | |
| 617-022-00-7 | mixture of: 1,2-dimethylpropylidene dihydroperoxide;
dimethyl 1,2-benzenedicarboxylate | | 442-480-8 | — | O; R7
Xn; R22
C; R34
R43
N; R51-53 | O; C; N
R: 7-22-34-43-51/53
S: (1/2-)3/7-14-26-36/37/39-45-50-61 | | |
| 647-017-00-5 | laccase | | 420-150-4 | 80498-15-3 | R42 | Xn
R: 42
S: (2-)23-45 | | |
The entries in Annex I with the following Index numbers are deleted:
024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.
[^1]: .